1
|
Lassen MH, Modin D, Skaarup KG, Claggett B, Solomon SD, Fralick M, Staehr-Jensen JU, Sivapalan P, Schou M, Krause TG, Hviid A, Koeber L, Torp-Pedersen C, Gislason G, Biering-Soerensen T. Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Large randomized controlled trials (RCT) have shown that COVID-19 vaccines are effective at preventing severe COVID-19. However, the RCT's are not powered to detect rare adverse events. It has been reported that the new mRNA based COVID-19 vaccines may increase the risk of thromboembolic and ischemic events. Likewise, thromboembolic and ischemic events are also known complications to infection with SARS-CoV-19. Currently, less is known about the risk-reward relationship of receiving an mRNA-based COVID-19 vaccine versus contracting COVID-19 infection with respect to thromboembolic and ischemic outcomes.
Purpose
To compare the risk of thromboembolic and ischemic events following COVID-19 vaccination to the risk following infection with SARS-CoV-19.
Methods
The study period was from March 2020 to August 2021. All individuals were >18 years old. The population was stratified into two different groups. The vaccinated group consisted of recipients of the first dose of either Moderna (mRNA-1273, n=488,220) or Pfizer-BioNTech (BNT162b2 mRNA, n=3,186,164) vaccines. Individuals who had previously tested positive for SARS-CoV-19 were excluded. The other group consisted of individuals who had tested positive for SARS-CoV-19 in the same period who had not yet received their first vaccination dose (n=233,926). The exposure period for both groups was set to 28 days following vaccination/testing positive for SARS-CoV-19 (Figure 1). Patient level data were obtained on all included individuals using nationwide registries. Primary outcomes were acute myocardial infarction (AMI), ischemic stroke, pulmonary embolism (PE), and deep venous thrombosis (DVT). Odds ratios were obtained from logistic regression models with the vaccinated group acting as reference. Multivariable models were adjusted for demographics and comorbidities.
Results
In the vaccinated group, mean age was 53±19 years and 50.3% were female. In the group of participants testing positive for SARS-CoV-19, mean age was 42.1±17.4 years and 50.2% were female. In total, 773 suffered a stroke, 472 suffered a PE, 500 suffered an AMI, and 484 suffered a DVT during the 28-day exposure period. We observed an increased absolute risk of all outcomes for participants testing positive for SARS-CoV-19 as compared to participants being vaccinated (stroke: 0.049% vs 0.019%, p<0.001), (PE: 0.91% vs 0.0072%, p<0.001), (AMI: 0.021 vs 0.013, p=0.0004), and (DVT: 0.037% vs 0.011%, p<0.001). In multivariable models, participants testing positive for SARS-CoV-19 had a significantly increased risk of all outcomes compared to participants being vaccinated: (stroke: OR: 4.0, 95% CI: [2.9–5.6], p<0.001), (PE: OR: 38.6 95% CI: [30.3–48.5], p<0.001), (AMI: OR: 3.3, 95% CI: [2.1–5.00], p<0.001), and (DVT: OR: 5.3, 95% CI: [3.8–7.5], p<0.001) (Figure 2).
Conclusion
The risks of thromboembolic and ischemic events were substantially higher after SARS-CoV-19 infection than after vaccination in the Danish population.
Funding Acknowledgement
Type of funding sources: Public hospital(s). Main funding source(s): Gentofte University Hospital
Collapse
Affiliation(s)
- M H Lassen
- Gentofte University Hospital, Cardiology , Copenhagen , Denmark
| | - D Modin
- Gentofte University Hospital, Cardiology , Copenhagen , Denmark
| | - K G Skaarup
- Gentofte University Hospital, Cardiology , Copenhagen , Denmark
| | - B Claggett
- Harvard Medical School , Boston , United States of America
| | - S D Solomon
- Harvard Medical School , Boston , United States of America
| | - M Fralick
- University of Toronto , Toronto , Canada
| | | | - P Sivapalan
- Gentofte University Hospital , Gentofte , Denmark
| | - M Schou
- Gentofte University Hospital, Cardiology , Copenhagen , Denmark
| | - T G Krause
- Statens Serum Institut , Copenhagen , Denmark
| | - A Hviid
- Statens Serum Institut , Copenhagen , Denmark
| | - L Koeber
- Rigshospitalet - Copenhagen University Hospital , Copenhagen , Denmark
| | | | - G Gislason
- Gentofte University Hospital, Cardiology , Copenhagen , Denmark
| | | |
Collapse
|
2
|
Ravnkilde K, Skaarup K, Lassen MCH, Johansen ND, Benfari G, Nistri S, Jensen GB, Schnohr P, Moegelvang R, Biering-Soerensen T. Left atrial coupling index predicts heart failure and atrial fibrillation in the general population. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
It is well known that left atrial (LA) function and size can provide significant information regarding the risk of atrial fibrillation (AF) and heart failure (HF). The ratio of LA volume index and tissue doppler imaging a' (peak myocardial velocity of the left ventricle in late diastole exposing the atrial contraction) provides the LA volumetric/mechanical coupling index (LACi). LACI is a novel echocardiographic measurement which combines information of LA size and function in one measure with limited previous investigation.
Purpose
The aim of the present study was to investigate the prognostic value of LACi in relation to incident HF and AF in the general population.
Methods
The present study included 4,003 participants from a prospective general population. All participants were examined with echocardiography. Incident HF and AF were investigated as separate outcomes. Exclusion criteria were AF and/or HF at baseline. LACi was calculated as the index of LAVI (left atrial volume index) and peak tissue velocity at late diastole measured with pulsed wave Doppler at the septal base of the left ventricle.
Results
Mean age was 56±17 years, 57% were female, and median LACi was 2.3 [IQR: 1.8, 3.0]. The median follow-up time was 5.4 [IQR: 4.5, 6.3] years. A total of 82 and 164 developed HF and AF during follow-up, respectively. Median LACi was significantly higher among participants developing HF (2.6 [IQR: 2.1, 3.8], P<0.001) and AF (2.8 [IQR: 2.1, 4.1], P<0.001) compared to those who remained event free (2.3 [IQR: 1.8, 3.0]). Multivariable Cox proportional hazard regression models were constructed and adjusted for gender, age, smoking status, hypercholesterolemia, diabetes mellitus, ischaemic heart disease at baseline, hypertension, left ventricular ejection fraction and left ventricular diastolic function (E/e'). LACi was an independent predictor of incident HF and of AF in both univariable and multivariable Cox regression models (Figure 1). LACi remained a significant predictor of both HF and AF in a sensitivity analysis with subgroups in which LAVI was normal and enlarged, respectively (Figure 1).
Conclusion
LACi is an independent predictor of HF and AF in the general population.
Funding Acknowledgement
Type of funding sources: Other. Main funding source(s): The Danish Heart Foundation and The Metropolitan Region of Denmark.
Collapse
Affiliation(s)
- K Ravnkilde
- Gentofte University Hospital , Gentofte , Denmark
| | - K Skaarup
- Gentofte University Hospital , Gentofte , Denmark
| | - M C H Lassen
- Gentofte University Hospital , Gentofte , Denmark
| | - N D Johansen
- Gentofte University Hospital , Gentofte , Denmark
| | - G Benfari
- University of Verona, Section of Cardiology , Verona , Italy
| | - S Nistri
- CMSR Veneto Medica , Vicenza , Italy
| | - G B Jensen
- Bispebjerg University Hospital, The Copenhagen City Heart Study , Copenhagen , Denmark
| | - P Schnohr
- Bispebjerg University Hospital, The Copenhagen City Heart Study , Copenhagen , Denmark
| | - R Moegelvang
- Bispebjerg University Hospital, The Copenhagen City Heart Study , Copenhagen , Denmark
| | | |
Collapse
|
3
|
Nielsen A, Skaarup K, Hauser R, Johansen N, Lassen M, Inciardi R, Jensen G, Schnohr P, Moegelvang R, Biering-Soerensen T. Left atrial strain predicts heart failure in the general population. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Left atrial (LA) function has shown to be a significant predictor of cardiovascular outcomes. We sought to determine the prognostic value of LA strain in relation to incident heart failure (HF) in the general population.
Methods
The present study includes 3,540 participants from the general population without prevalent atrial fibrillation or HF. All participants underwent health examinations and echocardiography including measures of LA function by means of peak atrial longitudinal strain (PALS), peak atrial contraction strain (PACS), and LA strain during the conduit phase (LACS). Cox proportional hazards regressions were utilised to access the association between incident HF and LA strain parameters.
Results
Median age of the study population was 57 years (interquartile range: 40, 69) and 2,015 (57%) were female. During follow-up (median 5.4 years), 66 (2%) participants were diagnosed with HF. Participants who developed HF had lower PALS (26.4% vs. 36.6%, p<0.001), PACS (15.6% vs. 16.5%, p=0.016), and LACS (11.4% vs. 19.3%, p<0.001) at baseline. Lower values of all three LA strain parameters were associated with a higher risk of developing HF in univariable analysis (Figure 1 & 2). After multivariable adjustments for Framingham Risk Score and global longitudinal strain, PALS (HR=1.06, 95% CI [1.03; 1.09], p<0.001, per 1% decrease), PACS (HR=1.07, 95% CI [1.02; 1.12], p=0.003, per 1% decrease), and LACS (HR=1.05, 95% CI [1.01; 1.10], p=0.016, per 1% decrease) remained significantly associated with incident HF. However, in participants with normal-sized LA (LA volume index <34 ml/m2) and no ischemic heart disease (n=3,046), only PALS and PACS remained independent predictors of HF (Figure 2).
Conclusion
LA strain provides independent prognostic value regarding the risk of incident HF in the general population.
Funding Acknowledgement
Type of funding sources: Other. Main funding source(s): The Danish Heart Foundation and The Metropolitan Region of Denmark
Collapse
Affiliation(s)
- A Nielsen
- Gentofte University Hospital , Copenhagen , Denmark
| | - K Skaarup
- Gentofte University Hospital , Copenhagen , Denmark
| | - R Hauser
- Gentofte University Hospital , Copenhagen , Denmark
| | - N Johansen
- Gentofte University Hospital , Copenhagen , Denmark
| | - M Lassen
- Gentofte University Hospital , Copenhagen , Denmark
| | - R Inciardi
- Civil Hospital of Brescia , Brescia , Italy
| | - G Jensen
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | - P Schnohr
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | - R Moegelvang
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | | |
Collapse
|
4
|
Lassen MH, Skaarup KG, Johansen ND, Qasim AN, Jensen GB, Schnohr P, Moegelvang R, Biering-Soerensen T. The prognostic value of the ratio of early transmitral filling velocity to early diastolic strain rate in a large general population cohort. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The ratio of early transmitral filling velocity (E) to early diastolic strain rate (e'sr) (E/e'sr) has recently been proposed as a novel non-invasive measure of early LV filling pressure. Using two-dimensional speckle tracking derived e'sr instead of Doppler-derived e' circumvents several of the limitations known to the Doppler-based method including angle-dependency and the high susceptibility to sampling location. The prognostic value of E/e'sr in relation to cardiovascular morbidity and mortality has previously been demonstrated in a range of specific patient populations including patients with type 2 diabetes, heart failure, atrial fibrillation, and a smaller general population study.
Purpose
To investigate the prognostic value of E/e'sr in relation to major adverse cardiovascular events (MACE) in a large low-risk general population.
Methods
A total of 3,782 participants were included in the present study. All participants had a comprehensive echocardiographic examination performed and analyzed. Two-dimensional speckle tracking analysis was performed to determine e'sr. Additionally, participants answered a questionnaire and underwent a general health examination. The outcome was MACE defined as a composite of incident heart failure, acute myocardial infarction, and cardiovascular death. Cox proportional hazards regression models were used to assess the relationship between E/e'sr and MACE.
Results
The mean age of the study population was 56±17 years and 57.2% were female. Mean E/e'sr was 63.4±19.6cm, mean E/e' was 7.6±2.8, and mean left ventricular ejection fraction was 56.8±5.9%. During follow-up (median: 3.5 years, IQR: 2.6, 4.3) a total of 133 (3.5%) met the composite outcome. Increasing E/e'sr was significantly associated with MACE in a univariable model (Figure 1) with a Harrel's C-statistic of 0.73. Increasing E/e'sr remained significantly associated with MACE in a multivariable model adjusted for age, sex, smoking status, hypercholesterolemia, hemoglobin, diabetes, history of ischemic heart disease, hypertension, heart rate, LVEF <50%, systolic blood pressure, and left atrial volume index (HR=1.09 [95% CI: 1.03; 1.16], p=0.002, per 10cm increase). A total of 824 participants had an E/e' in the indeterminate zone (E/e' between 9 and 14). In this subgroup, E/e'sr remained significantly associated with MACE (HR=1.14 [95% CI: 1.01; 1.29], p=0.038, per 10cm increase). This was also the case in all participants with a E/e <14 (n=3,649) (HR=1.12 [95% CI: 1.02; 1.23], p=0.018, per 10cm increase).
Conclusion
In this large general population sample, E/e'sr provides independent prognostic information in relation to MACE. This was even the case in participants with normal E/e'.
Funding Acknowledgement
Type of funding sources: Public hospital(s). Main funding source(s): Gentofte University Hospital
Collapse
Affiliation(s)
- M H Lassen
- Gentofte University Hospital, Cardiology , Copenhagen , Denmark
| | - K G Skaarup
- Gentofte University Hospital, Cardiology , Copenhagen , Denmark
| | - N D Johansen
- Gentofte University Hospital, Cardiology , Copenhagen , Denmark
| | - A N Qasim
- University of California San Francisco, Division of Cardiology , San Francisco , United States of America
| | - G B Jensen
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | - P Schnohr
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | - R Moegelvang
- Rigshospitalet - Copenhagen University Hospital , Copenhagen , Denmark
| | | |
Collapse
|
5
|
Sengelov M, Noergaard JL, Lassen MCH, Skaarup KG, Schoeps LB, Marott JL, Johansen ND, Joergensen PG, Jensen GB, Schnohr P, Prescott E, Soegaard P, Moegelvang R, Biering-Soerensen T. Changes in myocardial tissue velocities over a decade: the Copenhagen City Heart study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The aim of the present study was to investigate the impact of cardiovascular risk factors – age, sex, hypertension, hypercholesterolemia, diabetes, smoking and obesity on Tissue Doppler imaging (TDI) measures of systolic and diastolic tissue velocities in the general population over a 10-year period. Identifying risk factors that are associated with changes in TDI velocities could lead to an improved understanding of the pathophysiology of the deteriorating heart and enable early preventive actions and strategies.
Methods
The study included 1128 members from the general population who participated in both the 4th and 5th Copenhagen City Heart Study. At both examination rounds, the participants underwent echocardiography. The examinations were 10 years apart. Conventional echocardiographic measures of cardiac structure and function and measures of TDI myocardial tissue velocities were obtained.
Results
Average change in s', e' and a' were −0.4±1.1 cm/s, −0.9±1.7 cm/s and 0.5±1.7 cm/s, respectively. After multivariable adjustments, older age (P<0.001) and higher systolic blood pressure (BP) (P=0.029) were found to be associated with a decrease in s' at follow-up. Male sex (P<0.001) was found to be associated with an increase in s'. Older age (P<0.001) and greater number of smoking pack-years (P=0.004) were associated with a decrease in e' at follow-up after multivariable adjustments. In addition, greater BMI (P=0.004) was significantly associated with a decrease in a'. Higher diastolic BP (P=0.004) and male sex (P=0.004) were associated with an increase in a'.
Conclusion
In the general population, overall systolic and diastolic function declined over a 10-year period. Both systolic and diastolic function as assessed by myocardial TDI velocities were affected by multiple conventional cardiovascular risk factors.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- M Sengelov
- Gentofte Hospital - Copenhagen University Hospital , Hellerup , Denmark
| | - J L Noergaard
- Gentofte Hospital - Copenhagen University Hospital , Hellerup , Denmark
| | - M C H Lassen
- Gentofte Hospital - Copenhagen University Hospital , Hellerup , Denmark
| | - K G Skaarup
- Gentofte Hospital - Copenhagen University Hospital , Hellerup , Denmark
| | - L B Schoeps
- Gentofte Hospital - Copenhagen University Hospital , Hellerup , Denmark
| | - J L Marott
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | - N D Johansen
- Gentofte Hospital - Copenhagen University Hospital , Hellerup , Denmark
| | - P G Joergensen
- Gentofte Hospital - Copenhagen University Hospital , Hellerup , Denmark
| | - G B Jensen
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | - P Schnohr
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | - E Prescott
- Bispebjerg and Frederiksberg Hospital , Frederiksberg , Denmark
| | - P Soegaard
- Aalborg University Hospital , Aalborg , Denmark
| | - R Moegelvang
- Rigshospitalet - Copenhagen University Hospital , Copenhagen , Denmark
| | | |
Collapse
|
6
|
Espersen C, Hauser R, Skaarup KG, Lassen MCH, Johansen ND, Olsen FJ, Jensen G, Schnohr P, Moegelvang R, Biering-Soerensen T. The prognostic value of right ventricular free wall and global longitudinal strain in the general population. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Right ventricular free wall (RVFWLS) and global longitudinal strain (RV4CLS) have been shown to be prognostic of adverse events in various patient groups including patients with heart failure (HF).
Purpose
We sought to investigate the prognostic value of RVFWLS and RV4CLS for the development of incident HF in participants from the general population.
Methods
Participants from the echocardiographic substudy of the 5th Copenhagen City Heart Study (2011–2015) without chronic ischemic heart disease or heart failure at baseline were included. RVFWLS and RV4CLS were obtained using two-dimensional speckle-tracking echocardiography from the RV-focused apical 4-chamber view. The primary endpoint was incident HF.
Results
Among 2,804 participants (mean age 55, 42% male), 45 (1.6%) developed HF during a median follow-up of 5.4 years (IQR 4.5–6.3). Both RVFWLS and RV4CLS were associated with increased risk of HF in univariable cox regression analysis (HR 1.07, 95% confidence interval (CI) 1.02–1.12, p=0.003, and HR 1.21, 95% CI 1.11–1.31, p<0.001, respectively). Upon adjustment for age, sex, hypertension, diabetes and body mass index (BMI), both RVFWLS and RV4CLS remained associated with increased risk of incident HF (HR 1.05, 95% CI 1.00–1.11, p=0.038 and HR 1.13, 95% CI 1.04–1.22, p=0.004, respectively).
Conclusion
RVFWLS and RV4CLS were associated with an increased risk of incident HF in participants from the general population independent of age, sex, hypertension, diabetes and BMI.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- C Espersen
- Gentofte University Hospital, Department of Cardiology , Gentofte , Denmark
| | - R Hauser
- Gentofte University Hospital, Department of Cardiology , Gentofte , Denmark
| | - K G Skaarup
- Gentofte University Hospital, Department of Cardiology , Gentofte , Denmark
| | - M C H Lassen
- Gentofte University Hospital, Department of Cardiology , Gentofte , Denmark
| | - N D Johansen
- Gentofte University Hospital, Department of Cardiology , Gentofte , Denmark
| | - F J Olsen
- Gentofte University Hospital, Department of Cardiology , Gentofte , Denmark
| | - G Jensen
- Bispebjerg and Frederiksberg University Hospital, The Copenhagen City Heart Study , Copenhagen , Denmark
| | - P Schnohr
- Bispebjerg and Frederiksberg University Hospital, The Copenhagen City Heart Study , Copenhagen , Denmark
| | - R Moegelvang
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology , Copenhagen , Denmark
| | | |
Collapse
|
7
|
Holt E, Skaarup KG, Lassen MCH, Johansen ND, Joergensen PG, Hauser R, Lind JN, Jensen G, Schnor P, Prescott E, Soegaard P, Moegelvang R, Biering-Soerensen T. The effects of smoking on cardiac structure and function in a general population. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cigarette smoking is the leading preventable cause of death worldwide. Smoking is known to cause coronary artery disease, but studies have also shown that smoking independently is associated with higher risk of heart failure. However, the link between smoking and cardiac structure and function is not yet fully examined.
Purpose
The aim of the study was to investigate the independent effect of cigarette smoking on cardiac structure and function in a general population using echocardiographic measures.
Methods
A prospective cohort of 3,874 participants from a general population free of prevalent heart disease underwent an echocardiographic examination including two-dimensional speckle-tracking analysis. Smoking history was obtained through a self-administered questionnaire, that generated three groups; current smokers (18.6%), former smokers (40.9%) and never smokers (40.5%). Pack-years were estimated from the questionnaire.
Results
After multivariable adjustment for age, sex, body mass index, hypertension, hypercholesterolemia, diabetes and lung function, current smokers had significantly alterations in septal thickness (1.1±0.2 cm, P=0.018) and relative wall thickness (0.4±0.1 cm, P=0.016) compared to never smokers. Furthermore, left ventricular mass index (LVMi) was increased in current smokers compared to never smokers (85.8±19.3 g/cm2, P=0.048). Reduced left ventricle systolic function as assessed by global longitudinal strain (GLS) was evident in current smokers compared to never smokers (19.1±2.3%, P<0.001). Additionally, after multivariable adjustment increasing pack-years was associated with decreases in left ventricular ejection fraction (LVEF) (β=−0.04, P=0.031), E/A ratio (β=−0.06, P<0.001) and GLS (β=−0.04, P=0.008). Comparing cardiac structure and function in never smokers, continuous smokers and former smokers after 10 years, showed that continuous smokers developed increased LVMi (Δ=3.97±17.48 g/cm2, P<0.001) and decreased GLS (Δ=−0.77±3.84%, P=0.04) and LVEF (Δ=−4.23±5.7, P<0.001) compared to never and former smokers.
Conclusion
In a large general population study without known heart disease, current smoking and accumulated pack-years were independently associated with alterations in cardiac structure and reduced systolic function. Furthermore, we found that continuous smokers over a 10-year period developed relatively worse systolic function and increased LV structure alterations compared to never smokers and to participants that stopped smoking during that period.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): The Copenhagen City Heart Study is funded by The Danish Heart Foundation andThe Metropolitan Region of Denmark.
Collapse
Affiliation(s)
- E Holt
- Herlev and Gentofte Hospital , Copenhagen , Denmark
| | - K G Skaarup
- Herlev and Gentofte Hospital , Copenhagen , Denmark
| | - M C H Lassen
- Herlev and Gentofte Hospital , Copenhagen , Denmark
| | - N D Johansen
- Herlev and Gentofte Hospital , Copenhagen , Denmark
| | | | - R Hauser
- Herlev and Gentofte Hospital , Copenhagen , Denmark
| | - J N Lind
- Herlev and Gentofte Hospital , Copenhagen , Denmark
| | - G Jensen
- Bispebjerg University Hospital , Copenhagen , Denmark
| | - P Schnor
- Bispebjerg University Hospital , Copenhagen , Denmark
| | - E Prescott
- Bispebjerg University Hospital, Department of Cardiology , Copenhagen , Denmark
| | - P Soegaard
- Aalborg University, Institute of Clinical Medicine , Aalborg , Denmark
| | - R Moegelvang
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology , Copenhagen , Denmark
| | | |
Collapse
|
8
|
Sindet-Pedersen C, Michalik F, Emanuel Strange J, Moelager Christensen D, Alexander Gerds T, Andersson C, Folke F, Biering-Soerensen T, Fosboel E, Torp-Pedersen C, Hilmar Gislason G, Koeber L, Schou M. Risk of worsening heart failure and all-cause mortality following mRNA COVID-19 vaccination in patients with heart failure: a Danish nationwide real-world safety study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
The studies investigating the safety and efficacy of the SARS-COV2 mRNA vaccines only included a limited number of heart failure patients and no separate analyses were performed regarding the safety of the vaccines in this patient population.
Purpose
The aims of this study were to investigate the risk of worsening heart failure and all-cause mortality associated with the SARS-COV-2 mRNA vaccines in a nationwide cohort of patients with heart failure.
Methods
Using the Danish nationwide registries, two cohorts were constructed; 1) all prevalent heart failure patients in 2019 and 2) all prevalent heart failure patients in 2021 who were vaccinated with either of the two mRNA vaccines (BNT162B2 or mRNA-1273). The patients in the two cohorts were matched 1:1 using exact exposure matching on age, sex, and duration of heart failure (intervals). For patients in the 2021 cohort, the index date was defined as the date of the patients' second vaccination. Patients in the 2019 cohort were assigned the index day and month of their 1:1 match in the 2021 cohort, but used the pre-vaccination index year 2019. The primary outcomes were worsening heart failure and all-cause mortality and secondary outcomes were myocarditis and venous thromboembolism. Standardized risks were estimated based on outcome-specific Cox regression analyses, and all models were standardized to age, sex, duration of heart failure, use of SGLT2 inhibitors or Entresto, ischemic heart disease, cancer, diabetes, atrial fibrillation, and admission with heart failure <90 days before index.
Results
The total study population comprised 101,786 patients, with 50,893 patients in each cohort. The median age of the study population was 74 (interquartile range (IQR); 66,81), and duration of heart failure was 4.1 (IQR: 2.0,6.7) years. The standardized risk of all-cause mortality within 90 days was 2.2% (95% CI: 2.1% to 2.4%) in the 2021 cohort and 2.6% (95% CI: 2.4% to 2.7%) in the 2019 cohort, showing a significantly lower risk difference for all-cause mortality in 2021 versus 2019 (risk difference: −0.3% (95% CI: −0.5% to −0.1%)) Figure 1)). The standardized risk of worsening heart failure within 90 days was 1.1% (95% CI: −1.0% to 1.2%) in the 2021 cohort and 1.1% (95% CI: 1.0% to 1.2%) in the 2019 cohort showing no significant difference in the risk of worsening heart failure between the two cohorts (risk difference: 0% (95% CI: −0.1% to 0.1%)). No significant differences were found for venous thromboembolism or myocarditis.
Conclusion
This study showed that the SARS-COV2 mRNA vaccines were not associated with an increased risk of worsening heart failure, venous thromboembolism or myocarditis, but was associated with a decreased risk of all-cause mortality. Our study may suggest that these vaccines are safe in heart failure patients.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): The Danish Heart FoundationLæge Sofus Carl Emil Friis og hustrus legat
Collapse
Affiliation(s)
- C Sindet-Pedersen
- Gentofte Hospital - Copenhagen University Hospital, Cardiology , Hellerup , Denmark
| | - F Michalik
- Gentofte Hospital - Copenhagen University Hospital, Cardiology , Hellerup , Denmark
| | - J Emanuel Strange
- Gentofte Hospital - Copenhagen University Hospital, Cardiology , Hellerup , Denmark
| | | | | | - C Andersson
- Boston University, Medicine , Boston , United States of America
| | - F Folke
- Gentofte Hospital - Copenhagen University Hospital, Cardiology , Hellerup , Denmark
| | - T Biering-Soerensen
- Gentofte Hospital - Copenhagen University Hospital, Cardiology , Hellerup , Denmark
| | - E Fosboel
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology , Copenhagen , Denmark
| | - C Torp-Pedersen
- Nordsjaellands Hospital, Clinical Research and Cardiology , Hilleroed , Denmark
| | - G Hilmar Gislason
- Gentofte Hospital - Copenhagen University Hospital, Cardiology , Hellerup , Denmark
| | - L Koeber
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology , Copenhagen , Denmark
| | - M Schou
- Gentofte Hospital - Copenhagen University Hospital, Cardiology , Hellerup , Denmark
| |
Collapse
|
9
|
Lundberg S, Knigge P, Wagner AK, Strange JE, Gislason G, Andersson C, Biering-Soerensen T, Koeber L, Fosboel E, Schou M. Temporal trends in infection-related hospitalizations in patients with heart failure: a nationwide study from 1997 to 2017. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Over the last 20 years mortality has decreased for patients with heart failure (HF). However, re-hospitalization for HF is still a challenge. Further, whether the improved survival has resulted in increased rates of non HF hospitalization is unknown.
Purpose
This study examined the temporal trends in infection-related hospitalizations among new-onset HF patients and compared it to temporal trends in risk of worsening HF and death.
Methods
The study population included all Danish patients aged between 18 and 100 years old, with new-onset HF (defined according to the ICD10-code system) diagnosed between 1st January 1997 and 31st December 2017. Patients who were diagnosed with any type of cancer up to five years before their HF diagnosis were excluded to avoid cancer related infections.
The outcomes of interest were infections (defined according to the ICD10-code system) and worsening of heart failure (defined as a hospital admission with HF covering at least to dates).
The Aalen Johansen's estimator was used to estimate unadjusted 5-year absolute risk for all outcomes. Furthermore, a multivariate Cox analysis was made, and hazard ratios were estimated for the four time periods presented in a forest plot with the period 1997–2001 being the reference group. Adjustments for sex, age and history of comorbidities were conducted. Additionally, we stratified the infection outcome on different types of infections illustrated in 5-year cumulative incidence curves.
Results
The total population consisted of 147,737 patients. Over time there was a slight decrease in median age (1997–2001: 76.8 years, 2011–2017: 73.1 years) and the patients were more likely to be male (1997–2001: 53.5%, 2011–2017: 60%).
Figure 1 illustrates overall absolute risk of death decreased over time 1997–2001 (62.7% [95% CI 62.2–63.2]) vs. 2011–2017 (57.9% [95% CI 41.5–42.7]). Unadjusted curves for absolute risk showed that patients with HF had a higher risk of infection over time 1997–2001 (16.4% [95% CI 16.0–16.8] vs. 2011–2017 (24.5% [95% CI 24.0–24.9]). In contrast, they have a lower risk of worsening HF 1997–2011 (26.5% [95% CI 26.1–27.0] vs. 2011–2017 (23.2% [95% CI 22.8–23.7]). Adjusted analyses provided the same result for all outcomes illustrated in figure 2.
The risk of infection stratified by infection type, mark the risk of pneumonia infection as the most significant in all subintervals 1997–2001 (11.4% [95% CI 11.1–11.7]) vs. 2011–2017 (16.1% [95% CI 15.7–16.5]). The second most important was the risk of urogenital infection 1997–2001 (3.5% [95% CI 3.31–3.69]) vs. 2011–2017 (7.8% [95% CI 7.52–8.12]).
Conclusion
In this nationwide study, we observed that overall mortality risk and risk of hospitalization for worsening HF decreased from 1997 to 2017. In contrast, an increase in the risk of hospitalization for infection, especially pneumonia infections, increased during the same period. Future HF management programs should include strategies to prevent infections.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Lundberg
- Herlev and Gentofte Hospital, Department of Cardiology , Copenhagen , Denmark
| | - P Knigge
- Herlev and Gentofte Hospital, Department of Cardiology , Copenhagen , Denmark
| | - A K Wagner
- Herlev and Gentofte Hospital, Department of Cardiology , Copenhagen , Denmark
| | - J E Strange
- Herlev and Gentofte Hospital, Department of Cardiology , Copenhagen , Denmark
| | - G Gislason
- Herlev and Gentofte Hospital, Department of Cardiology , Copenhagen , Denmark
| | - C Andersson
- Boston University, Section of Cardiovascular Medicine , Boston , United States of America
| | - T Biering-Soerensen
- Herlev and Gentofte Hospital, Department of Cardiology , Copenhagen , Denmark
| | - L Koeber
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology , Copenhagen , Denmark
| | - E Fosboel
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology , Copenhagen , Denmark
| | - M Schou
- Herlev and Gentofte Hospital, Department of Cardiology , Copenhagen , Denmark
| |
Collapse
|
10
|
Landler N, Olsen FJ, Bro S, Feldt-Rasmussen B, Hansen D, Kamper AL, Christoffersen C, Ballegaard ELF, Soerensen IMH, Bjergfelt SS, Seidelin E, Biering-Soerensen T. Early diastolic strain rate and its associations with estimated glomerular filtration rate and albuminuria. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The ratio of early diastolic inflow to early diastolic strain rate, E/e'sr, is a novel echocardiographic measure, which has been shown to correlate better with left ventricular (LV) filling pressures than the conventionally used measure, E/e' (1). Additionally, E/e'sr has demonstrated prognostic value in various patient populations (2). Patients with chronic kidney disease (CKD) suffer frequently of diastolic dysfunction and elevated filling pressures (3). We wanted to investigate, how E/e'sr associates with two central measures of kidney function: estimated glomerular filtration rate, eGFR, and urine albumin creatinine ratio, UACR.
Methods
We enrolled a cohort of 825 ambulatory patients with CKD at the Departments of Nephrology of two university hospitals. Participants were examined with echocardiography including tissue doppler imaging. Two-dimensional speckle strain analysis was performed in all three apical standard projections. LV mass index (LVMI), E/e' and global longitudinal strain (GLS) were determined according to guidelines (4,5). Global early diastolic strain rate, e'sr, was calculated as the average of all 18 segments and indexed to early transmittal inflow velocity in order to calculate E/e'sr. Multivariable linear regression models were used to investigate associations between e'sr, E/e'sr, E/e' and kidney parameters. Models were adjusted for eGFR, UACR, LV ejection fraction (LVEF), age, sex, ever smoker, diabetes, hypertension, systolic and diastolic blood pressure (BP), heart rate and body mass index (BMI). We performed sensitivity analysis by excluding patients with known coronary artery disease (CAD) and heart failure (HF).
Results
Seventy-six patients had no measures of E/e'sr available leaving 749 for analysis. Excluding patients with CAD and/or HF (n=88) left 661 patients. For clinical and echocardiographic variables, see table. Patients with lower e'sr were older, had higher blood pressure and lower LVEF and GLS. E'sr was independently associated with eGFR and decreased 0.014 s–1 (95% CI 0.006 to 0.022, p=0.002) pr. 10 mL/min/1.73 m2 decrement of eGFR. Similarly, E/e'sr increased 1.1% (95% CI 0.2% to 19.2%) pr. 10 mL/min/1.73 m2 decrement of eGFR indicating rise in LV filling pressures. Contrary, E/e' was not independently associated with eGFR (p=0.5). Sensitivity analysis did not change the results significantly. None of the three measures were independently associated with UACR. Cubic restricted splines of e'sr, E/e'sr, E/e' over eGFR (figure) showed a non-linear relationship between E/e'sr and eGFR with accelerated increase at eGFR below 40 ml/min/1.73 m2.
Conclusion and perspectives
In patients with CKD, deformation-based e'sr and E/e'sr are independently associated with eGFR, but not with UACR. Repeated measurements and longitudinal follow-up of the cohort will provide information on the prognostic performance of these novel measures compared with conventional measures of LV filling pressure.
Funding Acknowledgement
Type of funding sources: Public hospital(s). Main funding source(s): The Capital Region of Denmark
Collapse
Affiliation(s)
- N Landler
- Gentofte University Hospital, Cardiovascular Non-Invasive Imaging Research Laboratory , Copenhagen , Denmark
| | - F J Olsen
- Gentofte University Hospital, Cardiovascular Non-Invasive Imaging Research Laboratory , Copenhagen , Denmark
| | - S Bro
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology , Copenhagen , Denmark
| | - B Feldt-Rasmussen
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology , Copenhagen , Denmark
| | - D Hansen
- Herlev-Gentofte Hospital - Copenhagen University Hospital, Department of Nephrology , Copenhagen , Denmark
| | - A L Kamper
- Herlev-Gentofte Hospital - Copenhagen University Hospital, Department of Nephrology , Copenhagen , Denmark
| | - C Christoffersen
- Rigshospitalet - Copenhagen University Hospital, Department of Clinical Biochemistry , Copenhagen , Denmark
| | - E L F Ballegaard
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology , Copenhagen , Denmark
| | - I M H Soerensen
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology , Copenhagen , Denmark
| | - S S Bjergfelt
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology , Copenhagen , Denmark
| | - E Seidelin
- Herlev-Gentofte Hospital - Copenhagen University Hospital, Department of Nephrology , Copenhagen , Denmark
| | - T Biering-Soerensen
- Gentofte University Hospital, Cardiovascular Non-Invasive Imaging Research Laboratory , Copenhagen , Denmark
| |
Collapse
|
11
|
Davidovski FS, Lassen M, Skaarup K, Olsen FJ, Sengeloev M, Ravnkilde K, Lindberg S, Fritz-Hansen T, Pedersen S, Iversen A, Galatius S, Gislason G, Moegelvang R, Biering-Soerensen T. Prognostic value of layer-specific global longitudinal strain in patients undergoing coronary artery bypass grafting. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Recent improvements in speckle tracking echocardiography have made sectionalized quantification of layer-specific global longitudinal strain (GLS) possible. Prior studies have reported prognostic value of GLS in several cardiac diseases, however, the use of layer-specific strain has not been investigated in patients undergoing coronary artery bypass grafting (CABG).
Purpose
To determine the prognostic value of layer-specific GLS for predicting all-cause mortality after CABG.
Methods
In this retrospective cohort study, consecutive patients undergoing isolated CABG between 2006 and 2011 were included. The patients were followed through nation-wide registries for the endpoint of all-cause mortality. Multivariable Cox regression models adjusted for clinical and echocardiographic baseline characteristics were used to assess the association between layer-specific GLS and all-cause mortality. Cumulative survival was stratified by clinical age and gender-dependent cut-off values for the layer-specific GLS, which was obtained from a large healthy population study.
Results
Of 641 patients included (mean age 67 years, 84% male), 70 (10.9%) died during follow-up (median 3.8 years [IQR: 2.7; 4.9 years]). Patients who died during follow-up were significantly older (71 years vs. 67 years, P = <0.001) and had a lower LVEF (46% vs. 51% P = <0.001). Endocardial GLS (GLSendo) (−14.2% vs. −16.3%, P<0.001), whole wall GLS (−12.1% vs. −13.9%, P<0.001), and epicardial GLS (GLSepi) (−10.6% vs. −12.2%, P<0.001) were all reduced in patients who died during follow-up, and patients with GLS below cut-off had a more than two-fold increased risk of all-cause mortality (Figure 1). The risk of dying increased linearly with decreasing absolute GLS for all layers (p<0.0002 for all layers), (Figure 2). In multivariable models, all layer-specific strain parameters remained significantly associated with all-cause mortality; GLSepi: HR=1.14 (1.05–1.23), p=0.002; GLS: HR=1.12 (1.04–1.20), p=0.002; GLSendo: HR=1.09 (1.03–1.16), p=0.003, per 1% absolute decrease. However, only GLSepi remained significantly associated with mortality when also adjusting for echocardiographic parameters (GLSepi: HR=1.12 (1.00–1.25), p=0.049, per 1% absolute decrease) and separately also after adjusting for the EuroScore II (GLSepi: HR=1.09 (1.00–1.18), p=0.043, per 1% absolute decrease).
Conclusion
Layer-specific GLS is an independent prognosticator of all-cause mortality after CABG. In multivariable models, GLSepi provided significant prognostic value after adjusting for echocardiographic parameters and EuroScore II.
Funding Acknowledgement
Type of funding sources: Public hospital(s). Main funding source(s): Research grant from Herlev & Gentofte University Hospital's internal research funds. Figure 1. Kaplan-Meier survival estimatesFigure 2. Incidence rate of all-cause mortality
Collapse
Affiliation(s)
- F S Davidovski
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - M Lassen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - K Skaarup
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - F J Olsen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - M Sengeloev
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - K Ravnkilde
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - S Lindberg
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - T Fritz-Hansen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - S Pedersen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - A Iversen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - S Galatius
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - G Gislason
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - R Moegelvang
- University of Copenhagen, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen, Denmark
| | | |
Collapse
|
12
|
Kaagaard MD, Matos LO, Wegener A, Holm AE, Gomes LC, Lima KO, Vieira IM, Souza RM, Marinho CF, Biering-Soerensen T, Silvestre OM, Brainin P. Diagnostic value of electrocardiograms to identify pericardial effusion in acute malaria: a cross-sectional study. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Patients with acute malaria are at risk of pericarditis and may benefit from timely identification of pericardial effusion. However, diagnostic imaging tools, such as echocardiography, are not always available in malaria endemic regions.
Purpose
The aim of this study is to examine the diagnostic yield of pathology in electrocardiograms (ECG) to identify pericardial effusion in acute malaria.
Methods
We enrolled adult acute malaria patients in community healthcare clinics in a remote area in South America. All patients underwent ECG, echocardiography, and peripheral blood smears. We excluded patients on anti-malarial medication, suspected concomitant infection and pregnant women. All ECGs were examined for the following criteria: (i) PR-depression >0.5mm and/or ST-elevation 0.5–1mm (I, II, aVL, aVF, V2–6) (ii) PR-elevation >0.5mm (only aVR), (iii) ST/T-ratio >0.25 (only V6), (v) low voltage, defined as QRS amplitude <5 mm in limb leads or <10 mm in precordial leads, and (vi) Spodick's sign (all leads). A criterion was positive when present in ≥2 leads. Information on shortness of breath and/or chest pain was also collected. Pericardial effusion was diagnosed by echocardiography and had to be ≥0.5cm in width.
Results
We included 99 non-severe malaria patients (age 40±15 years, 55% men, median parasite density 1517/mm3, [interquartile range 528 to 6,585/mm3]) who suffered from Plasmodium vivax (n=75), falciparum (n=22 falciparum) and mixed vivax/falciparum (n=2). The ECGs showed a mean frequency of 78±16bpm, PR-interval 147±20ms, QRS 88±11ms and QT-interval 376±34ms. A total of 11 patients displayed pericardial effusion (mean width 0.9±0.3cm, n=7 vivax, n=2 falciparum, n=2 mixed). Patients with effusion were older (mean age 39 vs 53 years, P=0.003), but displayed no difference in sex, parasite density or parasite species compared to patients without pericardial effusion (P>0.05). Distribution of ECG findings and symptoms are displayed in figure 1A. PR-depression had a sensitivity and specificity for diagnosing pericardial effusion of 73% and 90%, respectively. The sensitivity and specificity for other ECG findings and clinical symptoms are displayed in Figure 1B.
Conclusion
ECG findings may aid in identifying pericardial effusion in acute malaria, specifically PR depression which had a diagnostic yield of 73% sensitivity and 90% specificity. Based on this, ECG in acute malaria may improve treatment and risk stratification when echocardiography is not an option.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Novo Nordisk Foundation, Independent Research Fund Denmark ECG findings in malaria patients
Collapse
Affiliation(s)
- M D Kaagaard
- Gentofte University Hospital, Copenhagen, Denmark
| | - L O Matos
- UFAC - Federal University of Acre, Rio Branco, Brazil
| | - A Wegener
- Gentofte University Hospital, Copenhagen, Denmark
| | - A E Holm
- Gentofte University Hospital, Copenhagen, Denmark
| | - L C Gomes
- UFAC - Federal University of Acre, Rio Branco, Brazil
| | - K O Lima
- UFAC - Federal University of Acre, Rio Branco, Brazil
| | - I M Vieira
- UFAC - Federal University of Acre, Rio Branco, Brazil
| | - R M Souza
- UFAC - Federal University of Acre, Rio Branco, Brazil
| | | | | | - O M Silvestre
- UFAC - Federal University of Acre, Rio Branco, Brazil
| | - P Brainin
- Gentofte University Hospital, Copenhagen, Denmark
| |
Collapse
|
13
|
Holm AE, Gomes L, Lima KO, Matos LO, Wegener A, Vieira IVM, Souza RM, Marinho CRF, Biering-Soerensen T, Silvestre OM, Brainin P. Patient reported health status and cardiovascular risk factors in a remote area of South America: a cross-sectional study. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Several studies have indicated that self-perception of health is related to cardiovascular disease. Despite cardiovascular disease is the leading cause of mortality in South America, the relationship between patient reported health and cardiovascular risk is sparsely explored, specifically in indigenous areas.
Purpose
We assessed if self-rated health is associated with cardiovascular risk factors in a remote area in South America.
Methods
We included participants by cluster-randomization of community health care clinics from June to December 2020. Sociodemographic variables and information on cardiovascular risk factors were collected by questionnaires and physical examination. All participants rated their present health status according to the validated EQ5D-VAS instrument, ranging from 0 (worst) to 100 (best).
Results
A total of 492 participants (mean age 41±15 years; 38% men) were included. The mean value of self-rated health was 80 (range 0 to 100) and the prevalence of cardiovascular risk factors were: Hypertension (19%), hypercholesterolemia (15%), smoking (37%), low intake of vegetables (defined as <3 times per week; 54%), no sport activity (62%), diabetes (6%) and obesity (24%). In logistic regression models adjusted for sex, age and socioeconomic status, higher self-rated health was significantly associated with lower risk of hypertension, hypercholesterolemia, smoking, obesity and greater vegetable intake (P<0.05; Figure 1). No association was found with sport activity or diabetes. The total number of cardiovascular risk factors increased with lower self-rated health (beta = 0.100 [0.04 to 0.15], P<0.001 per 10 decrease in self-reported health).
Conclusion
Self-rated health was significantly associated with a greater burden of cardiovascular risk factors and may influence ideal cardiovascular health. Future studies should assess if patient reported health status constitutes an independent risk factor for heart disease in this specific population, and studies elucidating gaps on self-perception of cardiovascular health are encouraged.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): The Independent Research Fund Denmark
Collapse
Affiliation(s)
- A E Holm
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - L Gomes
- UFAC - Federal University of Acre, Federal University of Acre, Rio Branco, Brazil
| | - K O Lima
- UFAC - Federal University of Acre, Federal University of Acre, Rio Branco, Brazil
| | - L O Matos
- UFAC - Federal University of Acre, Federal University of Acre, Rio Branco, Brazil
| | - A Wegener
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - I V M Vieira
- UFAC - Federal University of Acre, Federal University of Acre, Rio Branco, Brazil
| | - R M Souza
- UFAC - Federal University of Acre, Federal University of Acre, Rio Branco, Brazil
| | | | | | - O M Silvestre
- UFAC - Federal University of Acre, Federal University of Acre, Rio Branco, Brazil
| | - P Brainin
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| |
Collapse
|
14
|
Bertelsen L, Diederichsen SZ, Frederiksen KS, Haugan KJ, Brandes A, Graff C, Krieger D, Hoejberg S, Olesen MS, Biering-Soerensen T, Koeber L, Vejlstrup N, Hasselbalch SG, Svendsen JH. Left atrial remodeling and cerebrovascular disease assessed by magnetic resonance imaging in patients undergoing continuous heart rhythm monitoring. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Atrial remodeling and atrial fibrillation (AF) have both been associated with cerebrovascular lesions. We wished to investigate the possible direct association between atrial remodeling and cerebrovascular disease including white matter lesions and lacunar infarcts in patients with and without atrial fibrillation (AF) as documented by implantable loop recorder (ILR).
Methods
Cardiac and cerebral MRI scans were acquired in a cross-sectional study including participants ≥70 years of age with stroke risk factors (history of hypertension, diabetes mellitus, congestive heart failure and/or previous stroke) but without known AF. Cerebrovascular disease was visually rated using the Fazekas scale and number of lacunar strokes. Left atrial (LA) (see figure) and ventricular volumes and function were analyzed, and associations between atrial remodeling and cerebrovascular disease were assessed with logistic regression models. Multivariable models were adjusted for sex, age, diabetes, hypertension, heart failure and history of stroke/transient ischemic attack. The analyses were stratified according to sinus rhythm or any AF during three months of continuous ILR monitoring to account for subclinical AF.
Results
Of 200 participants investigated, 87% had a Fazekas score≥1 and 45% had ≥1 lacunar infarct. Within three months of ILR implantation, AF was detected in 28 (14%) participants, while 172 (86%) had sinus rhythm only. Results are summarized in table. For participants with sinus rhythm, lower LA passive emptying fraction was associated with Fazekas score after multivariable adjustment, while LA total emptying fraction was borderline significant, and increased LA maximum and minimum volumes were associated with lacunar infarcts. There were no significant associations in patients with AF.
Sensitivity analyses showed similar results with longer screening periods for AF.
Conclusions
In patients free from AF as documented by ILR monitoring, we found an independent association between LA passive emptying and Fazekas score, and between atrial volumes and lacunar infarcts. This supports that atrial remodeling alone without AF is associated with an increased risk of cerebrovascular lesions.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): The Innovation Fund, DenmarkThe Research Foundation for the Capital Region of Denmark
Collapse
Affiliation(s)
- L Bertelsen
- Rigshospitalet - Copenhagen University Hospital, Heart Center, Copenhagen, Denmark
| | - S Z Diederichsen
- Rigshospitalet - Copenhagen University Hospital, Heart Center, Copenhagen, Denmark
| | - K S Frederiksen
- Rigshospitalet - Copenhagen University Hospital, Danish Dementia Research Centre, Department of Neurology, Copenhagen, Denmark
| | - K J Haugan
- Zealand University Hospital, Department of Cardiology, Roskilde, Denmark
| | - A Brandes
- Odense University Hospital, Department of Cardiology, Odense, Denmark
| | - C Graff
- Aalborg University, Department of Health Science and Technology, Aalborg, Denmark
| | - D Krieger
- University Hospital Zurich, Zurich, Switzerland
| | - S Hoejberg
- Bispebjerg University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M S Olesen
- Rigshospitalet - Copenhagen University Hospital, Heart Center, Copenhagen, Denmark
| | | | - L Koeber
- Rigshospitalet - Copenhagen University Hospital, Heart Center, Copenhagen, Denmark
| | - N Vejlstrup
- Rigshospitalet - Copenhagen University Hospital, Heart Center, Copenhagen, Denmark
| | - S G Hasselbalch
- Rigshospitalet - Copenhagen University Hospital, Danish Dementia Research Centre, Department of Neurology, Copenhagen, Denmark
| | - J H Svendsen
- Rigshospitalet - Copenhagen University Hospital, Heart Center, Copenhagen, Denmark
| |
Collapse
|
15
|
Nielsen A, Soerensen S, Skaarup K, Djernaes K, Estepar R, Hansen M, Worck R, Johannesen A, Hansen J, Biering-Soerensen T. Left atrial function assessed by speckle tracking echocardiography predicts atrial fibrillation burden after catheter ablation independently of reconduction: a RACE-AF echocardiographic sub-study. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Left atrial (LA) function assessed by 2D speckle tracking echocardiography (STE) has demonstrated to be a useful predictor of recurrence of atrial fibrillation (AF) following catheter ablation (CA). Pulmonary vein reconduction (PVR) is one of the most important causes of recurrent paroxysmal AF (PAF) after ablation. The purpose of this study was to evaluate the association between AF burden (% of time in AF) following CA and LA strain measurements independently of PVR.
Methods
This prospective study included 66 patients with PAF who underwent CA (mean age 60 ± 8 years, 65% male). STE was performed during sinus rhythm prior to CA. AF burden was recorded by continuous rhythm monitoring using implantable loop recorders during a follow-up period of 4-6 months, excluding a blanking period of 3 months. After follow-up, all patients underwent an invasive assessment of pulmonary vein isolation to test for PVR. Multivariable linear regression analysis was used to assess the association between AF burden and peak atrial longitudinal reservoir strain (PALS), peak atrial contraction strain (PACS) and peak atrial conduit strain (PCS).
Results
Prior to CA, median AF burden was 3.8% (IQR: 0.5, 17). During follow-up, 37 patients (56%) were free of AF while median AF burden was 0.7% (IQR: 0.2, 1.6) in patients with an AF burden of more than 0%. A total of 35 patients (54%) were found to have PVR after ablation. Patients with AF recurrence had significantly lower PACS compared to patients with no AF during follow-up (10% ± 6% vs. 14% ± 5%, p = 0.004). No differences in PALS and PCS were observed. Increased PACS remained independently associated with low AF burden following CA after multivariable adjustments for clinical characteristics, comorbidities, and PVR (β=-0.262, p = 0.049) (Figure 1). PALS and PCS did not remain significantly associated with AF burden.
Conclusion
Increased PACS is strongly associated with low AF burden after CA even after adjusting for PVR. This suggests that an analysis of LA function could be useful to stratify patients prior to CA and improve treatment strategies.
Abstract Figure.
Collapse
Affiliation(s)
- A Nielsen
- Gentofte University Hospital, Copenhagen, Denmark
| | - S Soerensen
- Gentofte University Hospital, Copenhagen, Denmark
| | - K Skaarup
- Gentofte University Hospital, Copenhagen, Denmark
| | - K Djernaes
- Gentofte University Hospital, Copenhagen, Denmark
| | - R Estepar
- Brigham and Women"s Hospital, Boston, United States of America
| | - M Hansen
- Gentofte University Hospital, Copenhagen, Denmark
| | - R Worck
- Gentofte University Hospital, Copenhagen, Denmark
| | - A Johannesen
- Gentofte University Hospital, Copenhagen, Denmark
| | - J Hansen
- Gentofte University Hospital, Copenhagen, Denmark
| | | |
Collapse
|
16
|
Ravnkilde K, Skaarup K, Grove GL, Modin D, Nielsen AB, Falsing MM, Iversen AZ, Pedersen S, Fritz-Hansen T, Galatius S, Jespersen T, Shah A, Gislason G, Biering-Soerensen T. Longitudinal change in cardiac structure and function following acute coronary syndrome stratified by culprit coronary artery lesion site. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Acute coronary syndrome (ACS) has adverse consequences for the myocardium and subsequent cardiac function and structure. No reports exist comparing the differences in impact of culprit coronary artery lesion site on longitudinal remodeling and changes left ventricular structure and function.
Method
A total of 299 ACS patients treated with PCI were included in the present study. All patients had two echocardiographic examinations performed. The first was performed median 2 (IQR: 1; 3) days following PCI, while the second was performed median 240 (IQR: 81; 881) days after the first. Patients were grouped based on culprit coronary artery lesion (left anterior descending artery (LAD), right coronary artery (RCA) and circumflex artery (Cx)). Patients with multiple lesions were excluded from the present study. Univariable linear regression analysis was utilised to assess the association between culprit coronary artery lesion site and longitudinal change in cardiac structure and function.
Results
Mean age was 63 ± 11 years and 77% were male. At follow-up, mean left ventricular ejection fraction was 42 ± 9% and global longitudinal strain (GLS) was -13 ± 4%. Culprit coronary artery lesion was allocated as follows; 168 ACS patients were treated in LAD, 95 patients were treated in RCA, and 36 patients were treated in Cx. In the linear regression analysis, LAD patients displayed a greater improvement in GLS (b =-0.116, p = 0.048) compared to the two other lesion sites. LAD patients had the poorest GLS at both baseline and follow-up echocardiography (Figure). RCA lesions were associated with the largest decrease in left atrial maximum volume (LAVmax) (b = -0.156, p = 0.011) and the largest increase in relative wall thickness (RWT) (b = 0.139, p = 0.030), consequently resulting in an LAVmax smaller and an RWT larger at follow-up than other lesion sites (Figure). Lastly, Cx lesions were significantly associated with the largest decrease in ratio between peak early diastolic transmitral flow velocity and peak early diastolic mitral annular tissue velocity (E/e’) (b = -0.262, P <0.001). Cx lesion patients were observed to have elevated E/e’ at baseline, which generally normalised at follow-up (Figure).
Conclusion
The present study suggests that culprit coronary artery lesion site has a differential impact on cardiac remodeling. This information can potentially aid the clinical understanding of cardiac structure and function following ACS according to coronary artery lesion site.
Abstract Figure
Collapse
Affiliation(s)
- K Ravnkilde
- Gentofte University Hospital, Gentofte, Denmark
| | - K Skaarup
- Gentofte University Hospital, Gentofte, Denmark
| | - GL Grove
- Gentofte University Hospital, Gentofte, Denmark
| | - D Modin
- Gentofte University Hospital, Gentofte, Denmark
| | - AB Nielsen
- Gentofte University Hospital, Gentofte, Denmark
| | - MM Falsing
- Gentofte University Hospital, Gentofte, Denmark
| | - AZ Iversen
- Gentofte University Hospital, Gentofte, Denmark
| | - S Pedersen
- Gentofte University Hospital, Gentofte, Denmark
| | | | - S Galatius
- Frederiksberg University Hospital, Department of Cardiology, Frederiksberg, Denmark
| | - T Jespersen
- Gentofte University Hospital, Gentofte, Denmark
| | - A Shah
- Brigham And Women"S Hospital, Harvard Medical School, Department of Cardiology, Boston, United States of America
| | - G Gislason
- Gentofte University Hospital, Gentofte, Denmark
| | | |
Collapse
|
17
|
Byrne C, Pareek M, Rujic D, Krogager M, Kragholm K, Biering-Soerensen T, Vaduganathan M, Olesen T, Olsen M, Bhatt D. Intensive versus standard blood pressure control and vascular procedures: insights from the Systolic Blood Pressure Intervention Trial. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The Systolic Blood Pressure Intervention Trial (SPRINT) found that intensive versus standard blood pressure control reduced cardiovascular (CV) morbidity and mortality. Previous studies have shown that control of blood pressure reduces the risk of stroke and is one of the most modifiable risk factors for carotid artery disease. On the other hand, data on effect of blood pressure control on peripheral artery disease are more diverse. In addition, it is unknown whether intensive blood pressure control affects the risk of vascular procedures.
Purpose
To assess the relationship between intensive blood pressure control and incident vascular procedures.
Methods
SPRINT was a randomized, controlled trial comprising 9,361 individuals ≥50 years of age at high CV risk but without diabetes who had a systolic BP (SBP) 130–180 mmHg. Patients were randomized to intensive (target SBP <120mmHg) or standard antihypertensive treatment (target SBP <140mmHg). The primary efficacy endpoint was the composite of acute coronary syndromes, stroke, heart failure, or death from CV causes. The primary safety endpoint was the composite of serious adverse events. We examined the risk of composite and individual vascular procedures with intensive versus standard blood pressure control. We further examined subgroup heterogeneity using interaction analyses.
Results
During a median follow-up time of 3.3 years (range 0–5.5 years), a total of 174 (1.9%) composite vascular procedures were recorded. Intensive blood pressure control did not significantly reduce the risk of composite vascular procedures (intensive blood pressure control, 76 (1.6%) versus standard blood pressure control, 98 (2.1%), hazard ratio 0.76, 95% confidence interval, 0.57 to 1.03; P=0.08) (Figure 1). Similarly, the risks of the individual endpoints of carotid angioplasty, carotid endarterectomy, peripheral angioplasty or thrombolysis, lower extremity amputation for ischemia and gangrene, surgical or vascular procedure for abdominal aortic aneurysm, surgical or vascular procedure for thoracic aortic aneurysm, and surgical or vascular procedure for other problems were not significantly affected (P≥0.05 for all). Intensive blood pressure control reduced the risk of peripheral vascular surgery (intensive blood pressure control, 7 (0.2%) versus standard blood pressure control, 21 (0.5%), hazard ratio 0.33, 95% confidence interval, 0.14 to 0.77; P=0.01), though this was based on a small number of events. The safety and efficacy of intensive BP lowering was not modified by chronic kidney disease, age, sex, race, previous cardiovascular disease, or baseline systolic blood pressure tertile (P≥0.05 for all).
Conclusions
In SPRINT, intensive versus standard blood pressure control did not reduce the risk of composite incident vascular procedures.
Figure 1. Vascular procedures
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- C Byrne
- Bispebjerg and Frederiksberg University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M Pareek
- Brigham and Women'S Hospital, Harvard Medical School, Heart & Vascular Center, Boston, United States of America
| | - D Rujic
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M.L Krogager
- Aalborg University Hospital, Department of Cardiology, Aalborg, Denmark
| | - K.H Kragholm
- Aalborg University Hospital, Department of Cardiology, Aalborg, Denmark
| | - T Biering-Soerensen
- Brigham and Women'S Hospital, Harvard Medical School, Heart & Vascular Center, Boston, United States of America
| | - M Vaduganathan
- Brigham and Women'S Hospital, Harvard Medical School, Heart & Vascular Center, Boston, United States of America
| | - T.B Olesen
- Odense University Hospital, Department of Endocrinology, Odense, Denmark
| | - M.H Olsen
- Holbaek Hospital, Department of Internal Medicine, Holbaek, Denmark
| | - D.L Bhatt
- Brigham and Women'S Hospital, Harvard Medical School, Heart & Vascular Center, Boston, United States of America
| |
Collapse
|
18
|
Byrne C, Pareek M, Biering-Soerensen T, Vaduganathan M, Krogager M, Kragholm K, McCullough M, Desai N, Olsen M, Bhatt D. Baseline and on-treatment serum potassium and mortality in high risk patients: the Systolic Blood Pressure Intervention Trial (SPRINT). Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Observational studies in patients with hypertension have indicated a U-shaped association between on-treatment serum potassium levels and short-time mortality. However, the association between long-time mortality and serum potassium, and the potential modification of this association by intensive blood pressure lowering, are yet to be explored.
Purpose
To assess the relationship between serum potassium levels, treatment response to intensive blood pressure lowering, and mortality.
Methods
SPRINT was a randomized, controlled trial in which 9,361 individuals ≥50 years of age, at high cardiovascular (CV) risk, but without diabetes, who had an systolic blood pressure (SBP) 130–180 mmHg, were randomized to intensive (target SBP <120mmHg) or standard antihypertensive treatment (target SBP <140mmHg). Patients with an estimated glomerular filtration rate (eGFR) <25 ml/min/1.73 m2 or end-stage renal disease were excluded. Serum chemistry was drawn at baseline, prespecified intervals, and at close out. On-treatment serum potassium was defined as the last measurement for each participant. We examined the prognostic implications (for death from CV causes and death from any cause) of baseline and on-treatment serum potassium, using restricted cubic splines, unadjusted and adjusted for demographic, clinical, and laboratory variables. We further explored the effects of intensive blood pressure lowering across the serum potassium spectrum using interaction analyses.
Results
A total of 9,336 individuals had a serum potassium measurement available at baseline and 9,233 individuals had at least one subsequent measurement. Mean serum potassium was similar between the two study groups (intensive 4.21 mmol/l vs. standard 4.20 mmol/l; P=0.74); however, on-treatment serum potassium was significantly lower in the intensive group (intensive 4.17 mmol/l vs. standard 4.20 mmol/l; P=0.001). Median follow-up was 3.3 years (range 0–4.8), with 365 deaths from any cause (3.9%) and 102 deaths from CV causes (1.1%) recorded during the study period. Baseline serum potassium appeared to be linearly associated with both types of mortality events (test for overall trend, P<0.05; test for non-linearity versus linearity, P>0.05) on unadjusted analysis. On-treatment serum potassium displayed a U-shaped curve with death from any cause (test for overall trend, P=0.004; test for non-linearity versus linearity, P=0.006), but was not significantly associated with death from CV causes (P>0.05) (Figure). Associations were completely lost upon multivariable adjustment (P>0.05). This was particularly due to adjustment for eGFR. The efficacy of intensive blood pressure lowering was not modified by baseline or on-treatment serum potassium (P>0.05).
Conclusions
Neither baseline nor on-treatment serum potassium levels were associated with death after multivariable adjustment, including renal function. The efficacy of intensive blood pressure lowering was not modified by serum potassium.
Serum Potassium and death
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- C Byrne
- Bispebjerg and Frederiksberg University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M Pareek
- Brigham and Women'S Hospital, Harvard Medical School, Heart & Vascular Center, Boston, United States of America
| | - T Biering-Soerensen
- Brigham and Women'S Hospital, Harvard Medical School, Heart & Vascular Center, Boston, United States of America
| | - M Vaduganathan
- Brigham and Women'S Hospital, Harvard Medical School, Heart & Vascular Center, Boston, United States of America
| | - M.L Krogager
- Aalborg University Hospital, Department of Cardiology, Aalborg, Denmark
| | - K.H Kragholm
- Aalborg University Hospital, Department of Cardiology, Aalborg, Denmark
| | - M McCullough
- Massachusetts General Hospital - Harvard Medical School, Corrigan Minehan Heart Center, Boston, United States of America
| | - N.R Desai
- Yale New Haven Hospital, Department of Cardiology, New Haven, United States of America
| | - M.H Olsen
- Holbaek Hospital, Department of Internal Medicine, Holbaek, Denmark
| | - D.L Bhatt
- Brigham and Women'S Hospital, Harvard Medical School, Heart & Vascular Center, Boston, United States of America
| |
Collapse
|
19
|
Brainin P, Lassen M, Joergensen P, Biering-Soerensen T, Andersen H, Rossing P, Jensen M. Cardiac time intervals predict major adverse cardiovascular events in individuals with type 1 diabetes without known heart disease. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cardiac time intervals, and in particular the myocardial performance index (MPI) which combines systolic and diastolic function, are associated with cardiovascular prognosis in various populations. We aimed to investigate if cardiac time intervals offer prognostic information on cardiovascular risk in individuals with type 1 diabetes (T1DM).
Methods
We prospectively included 1,088 individuals with T1DM without known heart disease (mean age 50±15 years; 53% male; duration of diabetes 26±15 years; 30% had albuminuria). All enrolled individuals underwent an echocardiographic examination with assessment of cardiac time intervals by color Tissue Doppler imaging M-mode. We evaluated the isovolumetric relaxation and contraction time (IVRT; IVCT) and ejection time (ET). The MPI was calculated as [(IVRT+IVCT)/ET]. In Cox proportional hazards models, we assessed major adverse cardiovascular events (MACE), a composite of incident heart failure or hospitalization for acute coronary syndrome or PCI/CABG. Multivariable models were adjusted for clinical information, pharmacotherapy and echocardiographic parameters.
Results
During the median follow-up time of 6 years [IQR 6, 7 years], 106 (10%) experienced MACE. In adjusted survival analyses the IVRT (HR: 1.13 per 10ms increase [1.01 to 1.26], P=0.026) and MPI (HR: 1.03 per 1 unit increase [1.01 to 1.04], P=0.005) were associated with MACE. Overall, the association between IVCT and outcome was borderline significant (HR: 1.15 per 10ms increase [0.97 to 1.36], P=0.10) while there was no association for ET (HR: 0.97 per 10ms increase [0.89 to 1.05], P=0.43). Sex modified the association for IVCT (P interaction<0.05) such that IVCT (HR: 1.23 per 10ms increase [1.02 to 1.49], P=0.027) and MPI (HR 1.03 per 1 unit increase [1.01 to 1.05], P=0.005; Figure) were associated with MACE in women but not in men.
Conclusion
Cardiac time intervals are positively associated with MACE in T1D without known heart disease. Furthermore, the association is modified by sex in that the IVCT and MPI provide independent and prognostic information on the risk of future cardiovascular events particularly in female individuals while not significant in men. These findings suggest sex differences in myocardial impairment related to T1D.
Association between MACE and MPI in DM1
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- P Brainin
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - M.C.H Lassen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - P.G Joergensen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - T Biering-Soerensen
- University of Copenhagen, Department of Biomedical Sciences, Copenhagen, Denmark
| | | | - P Rossing
- Steno Diabetes Center, Gentofte, Denmark
| | - M.T Jensen
- Hvidovre Hospital - Copenhagen University Hospital, Department of Cardiology, Hvidovre, Denmark
| |
Collapse
|
20
|
Brainin P, Jensen M, Biering-Soerensen T, Moegelvang R, Fritz-Hansen T, Vilsboell T, Rossing P, Joergensen P. Prognostic utility of early systolic lengthening by speckle tracking echocardiography in patients with type 2 diabetes. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Early systolic lengthening (ESL) has recently recognized as a predictor of cardiovascular events in patients with myocardial ischemia. Our aim was to evaluate the prognostic value of ESL in patients with type 2 diabetes.
Methods
In this prospective study we conducted speckle tracking examinations in 743 patients with type 2 diabetes (62% male; age 63±10 years; diabetes duration 11 [5, 17] years). Patients were free from interventricular conduction disturbances, atrial fibrillation, heart failure and ischemic heart disease at study inclusion. We assessed the ESL index, defined as: (−100 x [peak positive systolic strain / global longitudinal strain (GLS)]), and duration of ESL, defined as time from onset of QRS complex on the electrocardiogram to time of peak positive systolic strain. Measurements were averaged from 18 myocardial segments.
Results
During the median follow-up time of 4.8 years [IQR 4, 5.3 years], 93 (13%) patients experienced major adverse cardiovascular events (MACE), a composite of incident heart failure, myocardial infarction and cardiovascular death. Because GLS modified the association with MACE (P interaction <0.05), the population was stratified by the median GLS value (low >−15% and high ≤−15%). In patients with low GLS, the ESL index (HR 1.47 per 1% increase [1.12 to 1.93], P=0.005) and ESL duration (HR 1.73 per 1ms increase [1.10 to 2.72], P=0.017) were associated with MACE. Both associations remained significant in multivariable models adjusted for clinical, echocardiographic and speckle tracking measurements (Figure). No associations were found in patients with high GLS (Figure).
Conclusion
Assessment of ESL yields novel and independent prognostic information on major adverse cardiovascular events in patients with diabetes type 2 and reduced longitudinal strain.
Forest plot: ESL and risk of MACE by GLS
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- P Brainin
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - M.T Jensen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - T Biering-Soerensen
- University of Copenhagen, Department of Biomedical Sciences, Copenhagen, Denmark
| | - R Moegelvang
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - T Fritz-Hansen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | | | - P Rossing
- Steno Diabetes Center, Gentofte, Denmark
| | - P.G Joergensen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| |
Collapse
|
21
|
Bjerking L, Hansen K, Biering-Soerensen T, Engblom H, Erlinge D, Haarh-Pedersen S, Heitmann M, Hove J, Rader S, Strange S, Galatius S, Prescott E. Cost-effectiveness of adding a non-invasive acoustic rule-out test in the evaluation of patients with suspected stable angina pectoris. Design of the randomized multicenter FILTER-SCAD trial. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Patients with suspected stable coronary artery disease (CAD) are selected for further non-invasive or invasive diagnostic tests depending on their pre-test probability (PTP) of obstructive CAD. However, the PTP, based on age, sex, and type of angina, has shown to grossly overestimate the likelihood of obstructive CAD. Consequently, the use of diagnostic tests has increased over the last decades despite a low diagnostic yield (6–7%). The CAD-score is a risk stratification score for obstructive CAD measured using a novel non-invasive acoustic device, and when added to PTP has shown excellent rule-out capabilities.
Purpose
To investigate if the addition of the CAD-score to a standard diagnostic examination is superior in terms of reducing overall number of diagnostic procedures and non-inferior in terms of safety as compared to a standard PTP-guided strategy when evaluating patients with suspected stable CAD.
Methods
The FILTER-SCAD trial is a randomized, controlled, multicenter trial expected to include 2000 subjects ≥30 years of age without known CAD referred for outpatient assessment for suspected CAD at 5 hospitals in Denmark and Sweden. First subject was randomized on October 22, 2019.
Subjects will be randomized 1:1 to either 1) a control group undergoing standard diagnostic examination (SDE) according to current guidelines, or 2) an intervention group undergoing SDE plus a CAD-score measurement, using permuted block randomization stratified by study site and PTP (very low vs. low-intermediate). Follow-up will be 12 months for a primary endpoint of cumulative number of diagnostic tests and a combined secondary safety endpoint of all-cause death, non-fatal myocardial infarction, unstable angina pectoris, heart failure, and ischemic stroke. Questionnaires assessing symptom severity, quality of life, life style measures, and medical treatment will be collected at baseline, 3 months, and 12 months after randomization.
The study is powered to detect superiority in terms of cumulative number of diagnostic tests with a power of 80% and a significance level of 0.05, and non-inferiority on the safety endpoint with a power of 90% and a significance level of 0.05. The study is conducted in compliance to the principles of the Declaration of Helsinki of the World Medical Association. ClinicalTrials.gov ID: NCT04121949.
Results
One study site is currently enrolling. Preliminary baseline data is available on the first 77 (44% males) enrolled patients (median age 61 years IQR (51–72) and PTP 22% IQR (13–38)) showing successful randomization with even distribution of baseline characteristic between the two groups including sex, age, and PTP.
Perspectives
The FILTER-SCAD trial will investigate whether it is feasible to reduce resource consumption without compromising safety in the outpatient assessment of patients with suspected CAD using a simple, non-invasive acoustic device. Enrollment and follow-up are expected to be completed spring 2022.
Funding Acknowledgement
Type of funding source: Other. Main funding source(s): The company Acarix A/S har provided an unrestricted grant for the study. The Foundation “Fonden for Faglig Udvikling i Speciallægepraksis” has provided a grant for the study.
Collapse
Affiliation(s)
- L Bjerking
- Bispebjerg Frederiksberg Hospital - Copenhagen University Hospital, Departement of Cardiology, Copenhagen, Denmark
| | - K Hansen
- Bispebjerg Frederiksberg Hospital - Copenhagen University Hospital, Departement of Cardiology, Copenhagen, Denmark
| | - T Biering-Soerensen
- Herlev Gentofte Hospital - Copenhagen University Cardiology, Departement of Cardiology, Hellerup, Denmark
| | - H Engblom
- Skane University Hospital, Departement of Clinical Physiology, Lund, Sweden
| | - D Erlinge
- Skane University Hospital, Department of Cardiology, Lund, Sweden
| | - S Haarh-Pedersen
- Herlev Gentofte Hospital - Copenhagen University Cardiology, Departement of Cardiology, Hellerup, Denmark
| | - M Heitmann
- Bispebjerg Frederiksberg Hospital - Copenhagen University Hospital, Departement of Cardiology, Copenhagen, Denmark
| | - J Hove
- Amager Hvidovre Hospital - Copenhagen University Hospital, Center of Functional Imaging and Research, Hvidovre, Denmark
| | - S Rader
- Nordsjællands Hospital - Copenhagen University Hospital, Departement of Cardiology, Hillerød, Denmark
| | - S Strange
- The Danish Association of Practicing Medical Specialist, Copenhagen, Denmark
| | - S Galatius
- Bispebjerg Frederiksberg Hospital - Copenhagen University Hospital, Departement of Cardiology, Copenhagen, Denmark
| | - E Prescott
- Bispebjerg Frederiksberg Hospital - Copenhagen University Hospital, Departement of Cardiology, Copenhagen, Denmark
| |
Collapse
|
22
|
Holm A, Gomes L, Biering-Soerensen T, Silvestre O, Brainin P. Malaria and cardiovascular disease: a systematic review. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2817] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Myocardial tissue appears to be a favored site for the malaria parasite, and several studies have suggested that malaria may lead to myocardial dysfunction. Therefore, we conducted a systematic review of clinical studies reporting on malaria and cardiac disease.
Methods
We searched PubMed and Embase through January 2020. We applied strict inclusion criteria (Figure 1A) and assessed studies reporting on verified cardiac disease by paraclinical tests, ECG, cardiac biomarkers and echocardiographic findings. Two reviewers independently screened articles, extracted data and assessed the PRISMA guidelines.
Results
Twenty-eight articles were identified (published 1954–2020; n=19 case-reports, n=5 cohort studies, n=4 cross-sectional studies; Figure 1B), of which most were conducted in India (n=11) and Germany (n=4). The studies included a total of 2,221 malaria cases (mean age 42 years; 67% men; 41% complicated infection) and the distribution of species were: Plasmodium falciparum (n=15), vivax (n=12) and knowlesi (n=1). The most commonly reported cardiac diagnoses in case-reports were myocarditis (n=9), pericarditis (n=3) and acute myocardial infarction (n=4). Although the cohort and cross-sectional studies reported on different cardiac parameters (Figure 1C), a majority showed that malaria cases more often had elevated levels of cardiac biomarkers, ECG alterations and reduced left ventricular ejection fraction when compared to controls (P<0.05 for all).
Conclusion
Studies reporting on malaria and cardiovascular disease display considerable heterogeneity in terms of study design, severity and outcome measurements. Despite this, the included studies demonstrate a potential link between malaria and cardiac disease. This should be explored in future and larger hypothesis generating clinical studies.
Figure 1
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- A Holm
- Herlev and Gentofte Hospital, Copenhagen, Denmark
| | - L.C Gomes
- Federal University of Acre, Cardiology, Cruzeiro do Sul, Brazil
| | | | - O Silvestre
- Federal University of Acre, Cardiology, Cruzeiro do Sul, Brazil
| | - P Brainin
- Federal University of Acre, Cardiology, Cruzeiro do Sul, Brazil
| |
Collapse
|
23
|
Holm A, Brainin P, Sengeloev M, Joergensen P, Bruun N, Schou M, Pedersen S, Fritz-Hansen T, Biering-Soerensen T. The prognostic value of myocardial deformational patterns is reduced in patients with heart failure. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Early systolic lengthening (ESL) and postsystolic shortening are considered highly specific for myocardial ischemia. We aimed to investigate the prognostic potential of both deformational patterns in patients with heart failure (HF) and to determine if a history of ischemic heart disease modified this relationship.
Method
A total of 884 patients with systolic HF (66±12 years, male 73%, mean ejection fraction 28±9%) underwent speckle tracking echocardiography. Of these, 61% suffered from ischemic cardiomyopathy (ICM). Patients were followed for all-cause mortality. We assessed the ESL index: [−100x (peak positive strain/maximal strain)] and the postsystolic index (PSI): [100x (postsystolic strain/maximal strain)]. Both parameters were averaged across 18 myocardial segments.
Results
During a median follow-up of 3.4 years [interquartile range 1.9 to 4.8], 132 patients (15%) died. In multivariable survival analyses adjusted for potential confounders (age, sex, BMI, mean arterial pressure, cholesterol, heart rate, CABG/PCI, left ventricular ejection fraction and mass index, left atrial volume index, tricuspid annular plane systolic excursion, E-wave, E/e', deceleration time, and global longitudinal strain) neither the ESL index (HR 1.02 per 1% increase [0.97 to 1.08], P=0.40) nor PSI (HR 1.00 per 1% increase [0.98 to 1.01], P=0.69) were associated with all-cause mortality. ICM modified the relationship (P interaction unadjusted/adjusted=0.001/0.008; Figure) such that per 1% increase in ESL index in patients with ICM was significantly associated with all-cause mortality (unadjusted: HR 1.09 [1.04 to 1.15], P<0.001 and adjusted: HR 1.06 [1.00 to 1.13], P=0.045) but not in those without (unadjusted: HR 1.02 [1.01 to 1.03], P=0.002 and adjusted: HR 0.99 [0.90 to 1.09], P=0.086). ICM did not modify the relationship between PSI and all-cause mortality (P interaction unadjusted/adjusted=0.15/0.13).
Conclusion
Our results indicate that in this cohort of undifferentiated HF patients with reduced ejection fraction the prognostic value of deformational patterns was reduced. However, the ESL index may provide some information on prognosis in patients with ICM.
ESL and interaction with ICM
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- A Holm
- Herlev and Gentofte Hospital, Copenhagen, Denmark
| | - P Brainin
- Herlev and Gentofte Hospital, Copenhagen, Denmark
| | - M Sengeloev
- Herlev and Gentofte Hospital, Copenhagen, Denmark
| | | | - N.E Bruun
- Zealand University Hospital, Roskilde, Denmark
| | - M Schou
- Herlev and Gentofte Hospital, Copenhagen, Denmark
| | - S Pedersen
- Herlev and Gentofte Hospital, Copenhagen, Denmark
| | | | | |
Collapse
|
24
|
Lundorff I, Sengeloev M, Pedersen S, Modin D, Bruun N, Hansen T, Biering-Soerensen T, Godsk Joergensen P. Right ventricular speckle tracking in patients with heart failure – a comparison of right ventricular measures. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
RV dysfunction is associated with increased mortality and morbidity in patients with heart failure. Due to the complex shape and position of the RV, assessing RV function from echocardiographic images remains a challenge.
Purpose
We have previously found that global longitudinal strain from 2DSTE is superior to left ventricular ejection fraction (LVEF) in identifying HFrEF patients with high risk of mortality. In this study we wanted to examine RV 2DSTE in patients with HFrEF and compare its prognostic value to conventional RV measures.
Methods and results
Echocardiographic examinations were retrieved from 701 patients with HFrEF. RV estimates were analysed offline, and end point was all-cause mortality. During follow-up (median 39 months) 118 patients (16.8%) died. RV GLS and RV FWS remained associated with mortality after multivariable adjustment, independent of TAPSE (RV GLS: HR 1.07, 95% CI 1.02–1.13, p=0.010, per 1% decrease) (RV FWS: HR 1.05, 95% CI 1.01–1.09, p=0.010, per 1% decrease). This seemed to be caused by significant associations in men as TAPSE remained as the only independent prognosticator in women. All RV estimates provided prognostic information incremental to established risk factors and significantly increased C-statistics (TAPSE: 0.74 to 0.75; RVFAC: 0.74 to 0.75; RVFWS: 0.74 to 0.77; RVGLS: 0.74 to 0.77).
Conclusions
RV strain from 2DSTE was associated with mortality in patients with HFrEF, independent of TAPSE and established risk factors. Our results indicate that RV strain is particularly valuable in male patients, whereas in women TAPSE remains a stronger prognosticator.
RV GLS and the risk of mortality
Funding Acknowledgement
Type of funding source: Private company. Main funding source(s): PGJ reports receiving lecture fee from Novo Nordisk.
Collapse
Affiliation(s)
- I.J Lundorff
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M Sengeloev
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - S Pedersen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - D Modin
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - N.E Bruun
- Zealand University Hospital, Department of Cardiology, Roskilde, Denmark
| | - T.F Hansen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | | | - P Godsk Joergensen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| |
Collapse
|
25
|
Landler N, Bro S, Feldt-Rasmussen B, Hansen D, Kamper A, Freese E, Soerensen I, Seidelin E, Olsen N, Olsen F, Gislason G, Biering-Soerensen T. The Copenhagen chronic kidney disease echo study (COInCYDE). Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
The cardiovascular mortality of patients with chronic kidney disease (CKD) is 2–10 times higher than in the average population.
Purpose
To estimate the prevalence of abnormal cardiac function or structure across the stages CKD 1 to 5nonD.
Method
Prospective cohort study. Patients with CKD stage 1 to 5 not on dialysis, aged 30 to 75 (n=875) and age-/sex-matched controls (n=173) were enrolled consecutively. All participants underwent a health questionnaire, ECG, morphometric and blood pressure measurements. Blood and urine were analyzed. Echocardiography was performed. Left ventricle (LV) hypertrophy, dilatation, diastolic and systolic dysfunction were defined according to current ESC guidelines.
Results
63% of participants were men. Mean age was 58 years (SD 12.6 years). Mean eGFR was 46.7 mL/min/1,73 m (SD 25.8) for patients and 82.3 mL/min/1,73 m (SD 13.4) for controls. The prevalence of elevated blood pressure at physical exam was 89% in patients vs. 53% in controls. Patients were more often smokers and obese.
Left ventricular mass index (LVMI) was slightly, albeit insignificantly elevated at CKD stages 1 & 2 vs. in kontrols: 3.1 g/m2, CI: −0.4 to 6.75, p-value 0.08. There was no significant difference in LV-dilatation between patients and controls.
Decreasing diastolic and systolic function was observed at CKD stage 3a and later: LVEF decreased 0.95% (CI: −1.5 to −0.2), GLS increased 0.5 (CI: 0.3 to 0.8), and OR for diastolic dysfunction increased 3.2 (CI 1.4 to 7.3) pr. increment CKD stage group.
Conclusion
In accordance to previous studies, we observe in the CPHCKD cohort study signs of early increase of LVMI in patients with CKD stage 1 & 2. Significant decline in systolic and diastolic cardiac function is apparent already at stage 3 CKD.
Figure 1. Estimated GFR vs. GLS & histogram of GLS
Funding Acknowledgement
Type of funding source: Public hospital(s). Main funding source(s): The Capital Region of Denmark
Collapse
Affiliation(s)
- N Landler
- Gentofte University Hospital, Cardiovascular Research, Copenhagen, Denmark
| | - S Bro
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology, Copenhagen, Denmark
| | - B Feldt-Rasmussen
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology, Copenhagen, Denmark
| | - D Hansen
- Herlev-Gentofte Hospital - Copenhagen University Hospital, Department of Nephrology, Copenhagen, Denmark
| | - A.L Kamper
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology, Copenhagen, Denmark
| | - E Freese
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology, Copenhagen, Denmark
| | - I.M.H Soerensen
- Rigshospitalet - Copenhagen University Hospital, Department of Nephrology, Copenhagen, Denmark
| | - E Seidelin
- Herlev-Gentofte Hospital - Copenhagen University Hospital, Department of Nephrology, Copenhagen, Denmark
| | - N.T Olsen
- Gentofte University Hospital, Cardiovascular Research, Copenhagen, Denmark
| | - F.J Olsen
- Gentofte University Hospital, Cardiovascular Research, Copenhagen, Denmark
| | - G Gislason
- Gentofte University Hospital, Cardiovascular Research, Copenhagen, Denmark
| | | |
Collapse
|
26
|
Johnsen C, Sengeloev M, Joergensen P, Bruun N, Modin D, Alhakak A, Schou M, Gislason G, Fritz-Hansen T, Shah A, Biering-Soerensen T. Prognostic value of global longitudinal layer specific strain for patients with heart failure with reduced ejection fraction. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Novel echocardiographic software allows for layer-specific evaluation of myocardial deformation by 2-dimensional speckle tracking echocardiography. Endocardial, epicardial- and whole wall global longitudinal strain (GLS) may be superior to conventional echocardiographic parameters in predicting all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF).
Purpose
The purpose of this study was to investigate the prognostic value of endocardial-, epicardial- and whole wall GLS in patients with HFrEF in relation to all-cause mortality.
Methods
We included and analyzed transthoracic echocardiographic examinations from 1,015 patients with HFrEF. The echocardiographic images were analyzed, and conventional and novel echocardiographic parameters were obtained. A p value in a 2-sided test <0.05 was considered statistically significant. Cox proportional hazards regression models were constructed, and both univariable and multivariable hazard ratios (HRs) were calculated.
Results
During a median follow-up time of 40 months, 171 patients (16.8%) died. A lower endocardial (HR 1.17; 95% CI (1.11–1.23), per 1% decrease, p<0.001), epicardial (HR 1.20; 95% CI (1.13–1.27), per 1% decrease, p<0.001), and whole wall (HR 1.20; 95% CI (1.14–1.27), per 1% decrease, p<0.001) GLS were all associated with higher risk of death (Figure 1). Both endocardial (HR 1.12; 95% CI (1.01–1.23), p=0.027), epicardial (HR 1.13; 95% CI (1.01–1.26), p=0.040) and whole wall (HR 1.13; 95% CI (1.01–1.27), p=0.030) GLS remained independent predictors of mortality in the multivariable models after adjusting for significant clinical parameters (age, sex, total cholesterol, mean arterial pressure, heart rate, ischemic cardiomyopathy, percutaneous transluminal coronary angioplasty and diabetes) and conventional echocardiographic parameters (left ventricular (LV) ejection fraction, LV mass index, left atrial volume index, deceleration time, E/e', E-velocity, E/A ratio and tricuspid annular plane systolic excursion). No other echocardiographic parameters remained an independent predictors after adjusting. Furthermore, endocardial, epicardial and whole wall GLS had the highest C-statistics of all the echocardiographic parameters.
Conclusion
Endocardial, epicardial and whole wall GLS are independent predictors of all-cause mortality in patients with HFrEF. Furthermore, endocardial, epicardial and whole wall GLS were superior prognosticators of all-cause mortality compared with all other echocardiographic parameters.
Funding Acknowledgement
Type of funding source: Public hospital(s). Main funding source(s): Herlev and Gentofte Hospital
Collapse
Affiliation(s)
- C Johnsen
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M Sengeloev
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - P Joergensen
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - N Bruun
- University of Copenhagen, Department of Clinical Medicine, Copenhagen, Denmark
| | - D Modin
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - A Alhakak
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M Schou
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - G Gislason
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - T Fritz-Hansen
- Herlev and Gentofte Hospital, Department of Cardiology, Copenhagen, Denmark
| | - A Shah
- Brigham and Women's Hospital, Division of Cardiovascular Medicine, Boston, United States of America
| | | |
Collapse
|
27
|
Modin D, Claggett B, Joergensen ME, Koeber L, Benfield T, Schou M, Jensen JU, Solomon S, Trebbien R, Fralick M, Vardeny O, Pfeffer MA, Torp-Pedersen C, Gislason G, Biering-Soerensen T. 1347The flu vaccine and mortality in hypertension. A Danish nationwide cohort study. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0047] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Influenza infection is associated with an increased risk of acute myocardial infarction (AMI) and stroke. It is currently unknown whether influenza vaccination may reduce mortality in patients with hypertension.
Purpose
To determine whether influenza vaccination is associated with lower risks of death in hypertensive patients without significant cardiovascular or other chronic disease.
Methods
Using nationwide registers, we identified all patients with hypertension in Denmark during 9 consecutive influenza seasons in the period 2007–2016 who were treated with at least 2 different classes of antihypertensive medication (beta-blockers, diuretics, calcium antagonists or renin-angiotensin system inhibitors). Patients who were not 18–100 years old or had ischemic heart disease, heart failure, chronic obstructive lung disease, cancer or cerebrovascular disease were excluded. Prior to each influenza season we assessed the exposure to influenza vaccination. End-points were death from all causes, from AMI or stroke, or cardiovascular death. For each season, patients were followed from December 1 until April 1 the next year, spanning the period of high influenza activity in Denmark.
Results
A total of 608,452 Patients were followed for a median of 5 seasons (interquartile-range: 2–8 seasons), with total follow-up time of 975,902 person-years. The vaccine coverage during study seasons ranged from 26% to 36%. During follow-up, 21,571 patients died of all-causes (3.5%), 12,270 patients died of cardiovascular causes (2.0%) and 3,846 patients died of AMI/stroke (0.6%). Vaccination was associated with older age, Diabetes Mellitus, atrial fibrillation, lower educational level, lower income and higher medication use. In unadjusted analysis considering all seasons, vaccination was significantly associated with increased risk of all-cause death, cardiovascular death and death from AMI/stroke. However, following adjustment for season, age, sex, comorbidities, medications, income, education, and more, vaccination was significantly associated with reduced risks of all-cause death, cardiovascular death and death from AMI/stroke (Figure).
PY, person-years.
Conclusion
In a nationwide study spanning 9 consecutive influenza seasons including more than 600,000 hypertensive patients without significant cardiovascular disease identified through medication use, influenza vaccination was significantly associated with a reduced risk of death from all-causes, cardiovascular causes and AMI/stroke. Influenza vaccination may improve patient outcome in hypertension.
Acknowledgement/Funding
Daniel Modin was supported by the Herlev & Gentofte University Hospital Internal Research Fund and by the Novo Nordisk Foundation.
Collapse
Affiliation(s)
- D Modin
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - B Claggett
- Brigham and Womens Hospital, Cardiovascular Medicine Division, Boston, United States of America
| | - M E Joergensen
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - L Koeber
- Rigshospitalet, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - T Benfield
- Hvidovre Hospital, University of Copenhagen, Department of Infectious Diseases, Copenhagen, Denmark
| | - M Schou
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - J U Jensen
- Herlev & Gentofte Hospital, University of Copenhagen, Respiratory Medicine Section, Copenhagen, Denmark
| | - S Solomon
- Brigham and Womens Hospital, Cardiovascular Medicine Division, Boston, United States of America
| | - R Trebbien
- Statens Serum Institut, Department of Virus and Microbiological Special Diagnostics, Copenhagen, Denmark
| | - M Fralick
- University of Toronto, Department of Medicine, Toronto, Canada
| | - O Vardeny
- University of Minnesota, Center for Chronic Disease Outcomes Research, Minneapolis, United States of America
| | - M A Pfeffer
- Brigham and Womens Hospital, Cardiovascular Medicine Division, Boston, United States of America
| | - C Torp-Pedersen
- Aalborg University, Departments of Cardiology and Epidemiology/Biostatistics, Aalborg, Denmark
| | - G Gislason
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - T Biering-Soerensen
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| |
Collapse
|
28
|
Brainin P, Haahr-Pedersen S, Olsen FJ, Fritz-Hansen T, Jespersen T, Gislason GH, Biering-Soerensen T. 1270Early systolic lengthening in patients with ST-segment elevation myocardial infarction: a novel predictor of cardiovascular events. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0040] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Early systolic lengthening (ESL) may occur in ischemic myocardial segments with reduced contractile force. We sought to evaluate the prognostic potential of ESL in patients with ST-segment elevated myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).
Methods
We prospectively enrolled 372 patients with STEMI who were treated with primary PCI. All patients underwent a speckle tracking echocardiographic examination with a median of 2 days (interquartile range 1, 3 days) after the PCI. We assessed a novel viability index, the ESL index, defined as: (100 x [peak positive systolic strain/peak negative global strain]), obtained as the average value from all 18 segments. We also calculated ESL duration from 18 segments, defined as time from onset of QRS complex on the electrocardiogram to time to peak of positive systolic strain.
Results
During a median follow-up time of 5.3 years (interquartile range 2.5, 6.0), 145 (39%) experienced major adverse cardiovascular events (MACEs), which was a composite of incident heart failure, new myocardial infarction and all-cause mortality. The ESL index and ESL duration were significantly increased in culprit lesion areas (6.7±6.2% vs. 5.0±4.1% and 43±33ms vs. 33±24ms, P<0.001 for both). In Cox proportional hazards models the ESL index (HR 1.27 per 1% increase, 95% CI 1.13–1.43, P<0.001, Fig A) and ESL duration (HR 1.49 per 1ms increase, 95% CI 1.15–1.92, P=0.002, Fig B) yielded prognostic information on MACE. Both associations remained significant after adjusting for clinical (age, sex, hypertension, heart rate), echocardiographic (LVMI, E/e', WMSI, LVEF, postsystolic index) and invasive (postprocedural TIMI flow, TnI) confounders. Additionally, tertiles of the ESL index and ESL duration yielded significant prognostic information on MACE (Fig C-D).
ESL index and ESL duration and MACE
Conclusions
Assessment of ESL following primary PCI in patients with STEMI yields independent and significant prognostic information on the future risk of cardiovascular events.
Collapse
Affiliation(s)
- P Brainin
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | | | - F J Olsen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - T Fritz-Hansen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - T Jespersen
- University of Copenhagen, Department of Biomedical Sciences, Copenhagen, Denmark
| | - G H Gislason
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | | |
Collapse
|
29
|
Brainin P, Jensen MT, Biering-Soerensen T, Moegelvang R, Fritz-Hansen T, Vilsboell T, Rossing P, Joergensen PG. 3080Postsystolic shortening yields novel and independent prognostic information on cardiovascular events and mortality in patients with type 2 diabetes. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cardiovascular disease is the leading cause of death and disability in patients with type 2 diabetes. We aimed to evaluate if postsystolic shortening, a marker of impaired myocardial function, may provide prognostic information on cardiovascular events and mortality in patients with type 2 diabetes.
Method
We prospectively studied 783 patients with diabetes type 2 (63% male, age 65 [58, 70] years; HbA1c 54 [48, 65] mmol/mol; diabetes duration 11 [6, 17] years) who underwent speckle tracking echocardiography. Patients with left bundle branch block, atrial fibrillation and a history of heart failure and myocardial infarction were excluded. The primary endpoint was the composite of incident heart failure, myocardial infarction and cardiovascular death. The secondary endpoint was all-cause death. We defined the postsystolic index (PSI) as: [100x (maximum strain in cardiac cycle – peak systolic strain)/ (maximum strain in cardiac cycle)].
Results
During the median follow-up of 4.9 years [4.2, 5.3], 87 patients (11%) reached the primary endpoint and 80 (10%) died from any cause. Each 1% increase in the PSI was associated with the primary (HR 1.07 95% CI 1.02–1.13, P<0.001, Fig A) and secondary endpoint (HR 1.09 95% CI 1.04–1.14, P<0.001, Fig B). After adjusting for age, sex, hypertension, smoking, duration of diabetes, cholesterol, eGFR, left ventricular ejection fraction and mass index, E/A-ratio, deceleration time and left atrial volume index, the PSI remained an independent predictor of both endpoints; primary (HR 1.07 per 1% increase 95% CI 1.01–1.14, P=0.028) and secondary endpoint (HR 1.07 per 1% increase, 95% CI 1.01–1.14, P=0.022).
PSI and the endpoints
Conclusion
In patients with type 2 diabetes, assessment of PSI yields novel and independent prognostic information on cardiovascular events and mortality. Hence, PSI may offer guidance on risk stratification in patients with type 2 diabetes.
Collapse
Affiliation(s)
- P Brainin
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - M T Jensen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | | | - R Moegelvang
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - T Fritz-Hansen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| | - T Vilsboell
- University of Copenhagen, Clinical Medicine, Copenhagen, Denmark
| | - P Rossing
- University of Copenhagen, Clinical Medicine, Copenhagen, Denmark
| | - P G Joergensen
- Gentofte University Hospital, Cardiology, Copenhagen, Denmark
| |
Collapse
|
30
|
Frimodt-Moeller KE, Olsen FJ, Biering-Soerensen SR, Moegelvang R, Jespersen T, Schnohr P, Gislason G, Biering-Soerensen T. 3149Regional strain patterns according to hypertension and left ventricular hypertrophy in the general population. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0037] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
A pattern of reduced basal longitudinal strain (BLS) is often observed in hypertension (HT) and with altered left ventricular (LV) geometry. Whether this pattern is associated with poor outcome is unclear. We hypothesized that BLS becomes incrementally more impaired in the transition from HT to LV hypertrophy (LVH) and is a predictor of outcome.
Methods
We investigated 1,096 participants from a community-based cohort study who had an echocardiogram with speckle tracking performed. Regional strain was calculated as: BLS, midventricular and apical strain. The participants were stratified by LV geometry: LVH vs. non-LVH (LVH defined as left ventricular mass index >116 g/m2 for men and >96g/m2 for women). Outcome was major adverse cardiovascular events (MACE) defined as incident myocardial infarction, heart failure, and cardiovascular death.
Results
BLS and midventricular strain were significantly reduced when comparing normal participants without HT to participants with HT, whereas only BLS was reduced when comparing participants with HT to those with LVH (figure). Overall, patients with LVH showed both reduced BLS and midventricular strain (BLS: −17.5 vs −19.2%, p<0.001; midventricular strain: −19.2 vs. −19.9%, p=0.007 for LVH and non-LVH, respectively) compared to non-LVH, whereas apical strain was similar between groups.
During a median follow-up of 12.9 years (13.5; 14.9 years) there were 139 events. Only BLS was reduced in patients with MACE (BLS: −18.0 vs −19.1%, p=0.002) compared to patients without outcome. Both BLS and midventricular strain were univariable predictors of MACE in patients with LVH (BLS: HR=1.20 [1.04; 1.20], p=0.002; midventricular strain: HR=1.08 [1.00; 1.17], p=0.049) but not in patients without LVH (BLS: HR=1.02 [0.97; 1.08], p=0.46; midventricular strain: HR=1.01 [0.94; 1.07], p=0.88). Both measures were independent predictors after multivariable adjustment for clinical risk factors: age, gender, smoking, hypertension, and cholesterol (BLS: HR=1.08 [1.00; 1.16, p=0.048; midventricular strain: HR=1.10 [1.00; 1.20], p=0.049).
Regional strain by HT and LV geometry
Conclusion
BLS and midventricular strain, but not apical strain, becomes incrementally impaired in the transition from normal to LVH, and is associated with poor outcome. In regional strain analyses, BLS provides the highest predictive value for outcome in patients with LVH.
Acknowledgement/Funding
None
Collapse
Affiliation(s)
| | - F J Olsen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - S R Biering-Soerensen
- Frederiksberg Hospital, Copenhagen University Hospital, The Copenhagen City Heart Study, Copenhagen, Denmark
| | - R Moegelvang
- Frederiksberg Hospital, Copenhagen University Hospital, The Copenhagen City Heart Study, Copenhagen, Denmark
| | - T Jespersen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - P Schnohr
- Frederiksberg Hospital, Copenhagen University Hospital, The Copenhagen City Heart Study, Copenhagen, Denmark
| | - G Gislason
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | | |
Collapse
|
31
|
Andersen D, Moegelvang R, Schnohr P, Lange P, Modin D, Alhakak AS, Jensen MT, Sivapalan P, Jensen JUS, Gislason G, Biering-Soerensen T. P2442Myocardial performance index predicts mortality in people with obstructive lung function from the general population. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Forced expiratory volume in one second (FEV1) is a significant predictor of mortality in patients with obstructive lung function (OL). Whether echocardiography can be used to identify patients at high risk, and whether it provides incremental prognostic information on mortality in patients with OL, remains unknown.
Methods
In a large, low-risk general population study, 1873 participants underwent a health examination with spirometry and echocardiography, including tissue Doppler imaging (TDI). The myocardial performance index (MPI) was calculated as the sum of the isovolumic contraction time (IVCT) and the isovolumic relaxation time (IVRT) divided by the left ventricle ejection time (LVET). Spirometry included measurements of (FEV1) and the forced vital capacity (FVC). OL was defined as FEV1/FVC <0.70. The primary endpoint was all-cause mortality.
Results
The mean age was 59±16 years, 57% were women, 43% had hypertension, 11% had diabetes, and 6% had ischemic heart disease. Of the 1873 included participants, 288 (15%) were classified as having OL at baseline. During follow up (median 13.7 years (IQR 13.2–16.2)), 584 (31%) persons died, hereof 178 (62%) in the subgroup of participants with OL and 406 (26%) in the subgroup of participants with normal lung function.
OL was associated with presence of left ventricular hypertrophy (higher left ventricular mass index), impaired diastolic function (lower E, higher A, lower E/A ratio, longer deceleration time, lower e' and higher E/e'), lower global longitudinal strain, and higher MPI.
In unadjusted analysis, higher MPI was associated with all-cause mortality for participants with OL (HR=1.18 (1.11–1.26), p<0.001, per 0.1 increase) and for participants with normal lung function (HR=1.42 (1.34–1.50), p<0.001, per 0.1 increase). The predictive value of MPI was significantly modified by the presence of obstructive lung function (p<0.001).
After multivariable adjustment for age, sex, FEV1/FVC, heart rate, systolic blood pressure, smoking status, body mass index (BMI), hypertension, diabetes, ischemic heart disease, ischemic stroke and heart failure at baseline, MPI remained an independent predictor of all-cause mortality (HR=1.19 (1.06–1.34), p=0.004, per 0.1 increase) for participants with OL but not for participants with normal lung function (HR=1.02 (0.94–1.11), p=0.598, per 0.1 increase).
When adding the MPI to the updated Age, Dyspnea and Obstruction (ADO) index, MPI provided incremental prognostic information beyond the updated ADO index, as determined from a significant increase in the Harrell's C-statistics (0.785 to 0.792, p=0.003).
Conclusion
Presence of OL is associated with subtle impairment of left ventricular systolic function, impaired left ventricular diastolic function, and higher MPI. MPI is an independent predictor of mortality in people with OL and provides incremental prognostic information regarding all-cause mortality in this population.
Acknowledgement/Funding
Herlev & Gentofte University Hospital PhD fund
Collapse
Affiliation(s)
- D Andersen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - R Moegelvang
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - P Schnohr
- University of Copenhagen, Copenhagen, Denmark
| | - P Lange
- Herlev Hospital - Copenhagen University Hospital, Copenhagen, Denmark
| | - D Modin
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - A S Alhakak
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M T Jensen
- Rigshospitalet - Copenhagen University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - P Sivapalan
- Gentofte University Hospital, Department of Pulmonary Medicine, Copenhagen, Denmark
| | - J U S Jensen
- Gentofte University Hospital, Department of Pulmonary Medicine, Copenhagen, Denmark
| | - G Gislason
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | | |
Collapse
|
32
|
Rasmussen S, Olsen F, Pedersen S, Lindberg S, Nochioka K, Magnusson N, Bjerre M, Iversen K, Pareek M, Gislason G, Biering-Soerensen T. P4628A multiple biomarker approach for risk assessment after ST-segment elevation myocardial infarction. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Several biomarkers independently predict outcome following ST-segment elevation myocardial infarction (STEMI). We hypothesized that combining information from multiple circulating biomarkers with numerous pathophysiological pathways may improve biomarker risk stratification following a STEMI.
Method
This was a prospective study of 735 patients with STEMI treated with primary percutaneous coronary intervention. Seventeen biomarkers were drawn before revascularization, including adrenalin, noradrenalin, C-reactive protein (CRP), neutrophil gelatinase-associated lipocalin (NGAL), pro-atrial natriuretic peptide (pro-ANP), alfa-defensin, adiponectin, troponin I, hemoglobin, thrombocyte, and total leukocyte count. The primary outcome was a composite of cardiovascular death or heart failure (CVD/HF) identified by national registries. In the effort to identify the best model, the population was randomly split into two equally sized groups, a derivation cohort and a validation cohort. We used classification and regression tree (CART) analysis to develop a risk model. The identified risk model was hereafter applied to the whole cohort.
Results
Mean age was 63 years, 74% were male and 33% had hypertension. During a median follow-up time of 5.0 years (3.2; 5.0), we observed 185 primary events. After including all biomarkers in the initial model, the CART analysis created a risk model including pro-ANP, NGAL, and CRP (Figure 1a). The risk of CVD/HF increased incrementally with increasing risk group (Figure 1b). The risk remained significantly higher in groups 3 and 4 after multivariable adjustments (hazard ratio (HR)=3.38 [95% confidence interval (CI): 1.60; 7.16] p=0.001 and HR=6.55 [95% CI: 2.73; 15.76] p<0.001, respectively) when compared with group 1.
Figure 1
Conclusion
We developed a risk model based on multiple biomarkers (NGAL, CRP, and pro-ANP) determined from a CART analysis which may ease risk stratification after STEMI.
Acknowledgement/Funding
Sif Rasmussen received a scholarship grant from Herlev & Gentofte Hospital and the P. Carl Petersens Fond during preparation of this manuscript.
Collapse
Affiliation(s)
- S Rasmussen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - F Olsen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - S Pedersen
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - S Lindberg
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - K Nochioka
- Tohoku University Graduate School of Medicine, Department of Cardiovascular Medicin, Sendai, Japan
| | - N Magnusson
- Aarhus University, Department of Clinical Medicine, Aarhus, Denmark
| | - M Bjerre
- Aarhus University, Department of Clinical Medicine, Aarhus, Denmark
| | - K Iversen
- Herlev Hospital - Copenhagen University Hospital, Department of Cardiology, Copenhagen, Denmark
| | - M Pareek
- Hillerod Hospital, Department of Cardiology, Hillerod, Denmark
| | - G Gislason
- Gentofte University Hospital, Department of Cardiology, Copenhagen, Denmark
| | | |
Collapse
|
33
|
Hoeegholm Karsum E, Andersen DM, Modin D, Biering-Soerensen SR, Moegelvang R, Jensen G, Schnohr P, Gislason G, Biering-Soerensen T. P2441The prognostic value of left atrial dyssynchrony in the general population. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Parameters derived from left atrial (LA) speckle tracking such as LA peak reservoir strain and LA dyssynchrony are potent predictors of cardiovascular morbidity and mortality in various patient populations. However, whether LA dyssynchrony as evaluated by speckle tracking is associated with long-term outcome in the general population is currently unknown.
Methods
In a cohort study with participants from the general population 385 participants without atrial fibrillation (AF), ischemic heart disease (IHD), heart failure (HF) or previous ischemic stroke (IS) had a health examination and an echocardiogram, including LA speckle tracking, performed. LA dyssynchrony was defined as the standard deviation of the time to peak regional atrial reservoir strain values. The endpoints were all-cause mortality, a combined endpoint of AF and IS, and a combined endpoint of major adverse cardiovascular events (MACE) comprised of acute myocardial infarction (AMI), HF or cardiovascular death (CVD).
Results
Median LA dyssynchrony was 42 ms (IQR: 22–58 ms), 60% percent of included participants were women, mean age was 55 years (SD 16 years), 34% had hypertension and 7% had diabetes mellitus. During a median follow up of 16.1 years (IQR 15.0–16.3 years), 83 (22%) participants died, 60 (15%) reached the composite endpoint of AF and IS, and 38 (10%) reached the composite MACE endpoint.
Increasing LA dyssynchrony was associated with increasing age, lower estimated glomerular filtration rate, lower E/A ratio, lower e' and higher E/e'. In a univariable Cox regression, LA dyssynchrony was a significant predictor of all-cause mortality (HR 1.07, 95% CI 1.02–1.11, p=0.001, per 10 ms increase) but was not significantly associated with the combined endpoint of AF and IS (HR 1.05, 95% CI 1.00–1.10, p=0.064, per 10 ms increase) nor MACE (HR 1.04, 95% CI 0.98–1.12, p=0.22, per 10 ms increase). However, when adjusted for age, LA dyssynchrony did not predict all-cause mortality (HR 1.03, p=0.28), the combined endpoint of AF and IS (HR 1.01, p=0.83), or MACE (HR 0.99, p=0.88,). Similarly, after further adjustment for age, sex, smoking status, systolic blood pressure and cholesterol, LA dyssynchrony did not predict any of the study outcomes (All-cause mortality: HR 1.01, p=0.72) (AF and IS: HR 0.98, p=0.88) (MACE: HR 1.00, p=0.93).
Conclusion
In this general population study, LA dyssynchrony was not an independent predictor of all-cause mortality and did not predict MACE nor a composite outcome consisting of AF and IS.
Collapse
Affiliation(s)
| | - D M Andersen
- Gentofte University Hospital, Copenhagen, Denmark
| | - D Modin
- Gentofte University Hospital, Copenhagen, Denmark
| | | | - R Moegelvang
- Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
| | - G Jensen
- Gentofte University Hospital, Copenhagen, Denmark
| | - P Schnohr
- Gentofte University Hospital, Copenhagen, Denmark
| | - G Gislason
- Gentofte University Hospital, Copenhagen, Denmark
| | | |
Collapse
|
34
|
Busch N, Jensen MT, Goetze JP, Biering-Soerensen T, Fritz-Hansen T, Andersen HU, Gislason G, Vilsboell T, Rossing P, Joergensen PG. P3427Prognostic performance of echocardiography, electrocardiogram, albuminuria, plasma proBNP and hs-TnI in patients with type 2 diabetes. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
A range of diagnostic tests including echocardiography, albuminuria, electrocardiogram (ECG), plasma measurement of high sensitivity troponin T (hs-TnI) and pro-brain natriuretic peptide (proBNP) have been suggested as cardiovascular (CV) risk predictors in patients with type 2 diabetes. In this study we examined prognostic yield from these risk markers.
Methods
A total of 1,030 out-patients followed at a large secondary care diabetes clinic were recruited. Echocardiography was considered feasible in patients in sinus rhythm with adequate image quality (n=886). Abnormal echocardiography was defined as a left ventricular ejection fraction (LVEF) <50%; a ratio of early diastolic mitral inflow velocity to early diastolic septal annular velocity (E/e'septal) ≥15; increased left ventricular mass index (>95 g/m2 for women and >115 g/m2 for men) or left atrial volume index >34 ml/m2. ECG was performed in 983 patients and was considered abnormal in the presence of abnormal Q-waves; ST-T segment deviation or bundle branch block. We measured urine albumin (n=1,009) and proBNP/hs-TnI (n=933). The end-point of CV event was a composite of CV death and hospitalization with myocardial infarction/revascularization, stroke, peripheral artery disease or heart failure.
Results
The median follow-up was 4.7 years (interquartile range: 4.0 to 5.3) and 174 patients suffered an CVD event. All markers except hs-TnI were significantly (p<0.001) associated with the composite outcome: Abnormal echocardiogram: Hazard ratio (95% confidence interval): 2.39 (1.69–3.37); albuminuria 2.01 (1.47–2.76); abnormal ECG 2.35 (1.72–3.21); log2(proBNP) 1.60 (1.47–1.75) and hs-TnI 1.05 (0.92–1.19). The findings persisted after adjusting for clinical variables, but after adjusting for the other markers, only log2(proBNP) remained associated with the composite outcome (1.50 (0.20–1.73), p<0.001), figure. Measured by C-index model performance was highest with proBNP (0.70 (0.65–0.75)) and similar to clinical variables (0.71 (0.67–0.76)). Combining risk markers only resulted in very limited increase in C-index (echocardiogram, albuminuria, ECG and proBNP: 0.71 (0.66–0.76)).
Uni- and multivariables
Conclusions
This study identifies proBNP measurement in plasma over echocardiography, ECG and albuminuria for risk prediction in patients with type 2 diabetes. The diagnostic yield in considering more than one risk marker was limited in this population.
Collapse
Affiliation(s)
- N Busch
- Gentofte University Hospital, Copenhagen, Denmark
| | - M T Jensen
- Gentofte University Hospital, Copenhagen, Denmark
| | - J P Goetze
- Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
| | | | | | - H U Andersen
- Gentofte University Hospital, Copenhagen, Denmark
| | - G Gislason
- Gentofte University Hospital, Copenhagen, Denmark
| | - T Vilsboell
- Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
| | - P Rossing
- Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark
| | | |
Collapse
|
35
|
Modin D, Pedersen S, Fritz-Hansen T, Gislason G, Biering-Soerensen T. P6399Left atrial function determined by echocardiography predicts incident heart failure in STEMI patients treated with primary percutaneous coronary intervention. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Objectives
To assess the comparative effectiveness of LA functional parameters (LAEF and MinLAVI) with that of LA volume index (LAVI) in predicting HF following STEMI.
Background
Heart failure (HF) is common following STEMI. Enlarged left atrial (LA) volume determined by echocardiography is associated with adverse outcome following STEMI. However, whether echocardiographic parameters of LA function, such as the LA emptying fraction (LAEF) and the minimal LA volume index (MinLAVI), are superior to LAVI for predicting prognosis following STEMI is unknown.
Methods
A total of 369 STEMI patients without atrial fibrillation or heart failure treated with primary percutaneous coronary intervention (pPCI) were prospectively enrolled in the period September 2006 to December 2008. Patients underwent echocardiography shortly after STEMI. The maximal and minimal LA volume were measured using the biplane area-length method. LAVI, MinLAVI (minimal LA volume indexed to body surface area) and LAEF [(maximal LA volume − minimal LA volume) / maximal LA volume] were calculated. End-point was incident HF.
Results
During a median follow-up of 66 months (interquartile-range: 50–73 months), 68 patients (18%) were admitted for HF. In univariable analysis, both reduced LAEF and increased MinLAVI were significantly associated with an increased risk of HF (LAEF: HR 1.18, 95% CI 1.08–1.29, per 5% decrease, p<0.001) (MinLAVI: HR 1.35, 95% CI 1.09–1.67, per 5 mL/m2 increase, p=0.006) (Figure). In contrast, LAVI was not significantly associated with the development of HF (HR 1.03, 95% CI 0.87–1.22, per 5 mL/m2 increase, p=0.73) (Figure). Following adjustment for clinical, biochemical and echocardiographic variables, LAEF and MinLAVI remained independent predictors of HF, while the lack of association between LAVI and HF persisted (LAEF: HR 1.14, 95% CI 1.02–1.27, per 5% decrease, p=0.019) (MinLAVI: HR 1.31, 95% CI 1.02–1.69, per 5 mL/m2 increase, p=0.036) (LAVI: HR 1.05, 95% CI 0.86–1.29, per 5 mL/m2 increase, p=0.61). These results were replicated when treating death from all causes as a competing event in competing risk regression.
PY, person-years
Conclusion
In STEMI patients treated with pPCI, LAEF and MinLAVI measured by echocardiography shortly after infarction are superior to LAVI for predicting incident HF.
Collapse
Affiliation(s)
- D Modin
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - S Pedersen
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - T Fritz-Hansen
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - G Gislason
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| | - T Biering-Soerensen
- Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology, Copenhagen, Denmark
| |
Collapse
|
36
|
Brainin P, Biering-Soerensen S, Sengeloev M, Mogelvang R, Soegaard P, Jensen J, Biering-Soerensen T. 5011Post-systolic shortening by speckle tracking echocardiography provides independent prognostic information on cardiovascular morbidity and mortality in the general population. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.5011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
37
|
Cakmak H, Ural E, Sahin T, Al N, Emre E, Saracoglu E, Akbulut T, Ural D, Rangel I, Goncalves A, Sousa C, Rodrigues J, Macedo F, Silva-Cardoso J, Maciel M, Iliuta L, Nagata Y, Takeuchi M, Kuwaki H, Hasyashi A, Otani K, Yoshitani H, Osuji Y, Haberka M, Liszka J, Kozyra A, Tabor Z, Finik M, Gasior Z, Hasselberg N, Haugaa K, Brunet A, Kongsgaard E, Donal E, Edvardsen T, Sugano A, Seo Y, Sato K, Atsumi A, Yamamoto M, Machino T, Harimura Y, Kawamura R, Ishizu T, Aonuma K, Biering-Sorensen T, Hoffmann S, Mogelvang R, Iversen A, Fritz-Hansen T, Bech J, Jensen J, Flarup Dons M, Biering-Soerensen T, Skov Jensen J, Fritz Hansen T, Bech J, Chantal De Knegt M, Sivertsen J, Moegelvang R. Moderated Posters session * The prognostic value of myocardial deformation imaging in cardiomyopathy: 12/12/2013, 08:30-12:30 * Location: Moderated Poster area. Eur Heart J Cardiovasc Imaging 2013. [DOI: 10.1093/ehjci/jet228] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
38
|
Flarup Dons M, Biering-Soerensen T, Skov Jensen J, Fritz Hansen T, Chantal De Knegt M, Sivertsen J, Moegelvang R. Tissue doppler imaging as an independent predictor of outcome in patients with atrial fibrillation. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.p1126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|